Search
All Clinical Trials in Canada
A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 3905
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Recruiting
The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer.
The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: GSK Investigational Site, Tucson, Arizona +252 locations
GSK Investigational Site, Tucson, Arizona
GSK Investigational Site, Los Angeles, California
GSK Investigational Site, New Haven, Connecticut
GSK Investigational Site, Washington, District of Columbia
GSK Investigational Site, Deerfield Beach, Florida
GSK Investigational Site, Fort Lauderdale, Florida
GSK Investigational Site, Marietta, Georgia
GSK Investigational Site, Chicago, Illinois
GSK Investigational Site, Chicago, Illinois
GSK Investigational Site, Chicago, Illinois
GSK Investigational Site, Naperville, Illinois
GSK Investigational Site, Naperville, Illinois
GSK Investigational Site, Westwood, Kansas
GSK Investigational Site, Lexington, Kentucky
GSK Investigational Site, Louisville, Kentucky
GSK Investigational Site, Baton Rouge, Louisiana
GSK Investigational Site, Bethesda, Maryland
GSK Investigational Site, Ann Arbor, Michigan
GSK Investigational Site, Detroit, Michigan
GSK Investigational Site, Minneapolis, Minnesota
GSK Investigational Site, Joplin, Missouri
GSK Investigational Site, Saint Louis, Missouri
GSK Investigational Site, Saint Louis, Missouri
GSK Investigational Site, Grand Island, Nebraska
GSK Investigational Site, Omaha, Nebraska
GSK Investigational Site, Omaha, Nebraska
GSK Investigational Site, Lebanon, New Hampshire
GSK Investigational Site, Bronx, New York
GSK Investigational Site, New York, New York
GSK Investigational Site, New York, New York
GSK Investigational Site, New York, New York
GSK Investigational Site, New York, New York
GSK Investigational Site, Durham, North Carolina
GSK Investigational Site, Akron, Ohio
GSK Investigational Site, Cincinnati, Ohio
GSK Investigational Site, Cleveland, Ohio
GSK Investigational Site, Cleveland, Ohio
GSK Investigational Site, Cleveland, Ohio
GSK Investigational Site, Oklahoma City, Oklahoma
GSK Investigational Site, Oklahoma City, Oklahoma
GSK Investigational Site, Pittsburgh, Pennsylvania
GSK Investigational Site, Sioux Falls, South Dakota
GSK Investigational Site, Sioux Falls, South Dakota
GSK Investigational Site, Sioux Falls, South Dakota
GSK Investigational Site, Sioux Falls, South Dakota
GSK Investigational Site, Dallas, Texas
GSK Investigational Site, Dallas, Texas
GSK Investigational Site, Richmond, Virginia
GSK Investigational Site, Appleton, Wisconsin
GSK Investigational Site, Buenos Aires, Not set
GSK Investigational Site, Buenos Aires, Not set
GSK Investigational Site, Buenos Aires, Not set
GSK Investigational Site, Capital Federal, Not set
GSK Investigational Site, Ciudad Autonoma de Buenos Aire, Not set
GSK Investigational Site, Cordoba, Not set
GSK Investigational Site, Mar del Plata, Not set
GSK Investigational Site, Rosario, Not set
GSK Investigational Site, San Miguel de TucumAn, Not set
GSK Investigational Site, Santa Fe, Not set
GSK Investigational Site, Newcastle, New South Wales
GSK Investigational Site, St Leonards, New South Wales
GSK Investigational Site, Woolangabba, Queensland
GSK Investigational Site, Heidelberg, Victoria
GSK Investigational Site, Melbourne, Victoria
GSK Investigational Site, Aalst, Not set
GSK Investigational Site, Bruxelles, Not set
GSK Investigational Site, Bruxelles, Not set
GSK Investigational Site, Edegem, Not set
GSK Investigational Site, Gent, Not set
GSK Investigational Site, Leuven, Not set
GSK Investigational Site, LiEge, Not set
GSK Investigational Site, Roeselare, Not set
GSK Investigational Site, Barretos, Not set
GSK Investigational Site, Lages, Not set
GSK Investigational Site, Natal, Not set
GSK Investigational Site, Porto Alegre, Not set
GSK Investigational Site, Salvador, Not set
GSK Investigational Site, Sao Jose Do Rio Preto, Not set
GSK Investigational Site, Sao Paulo, Not set
GSK Investigational Site, Sao Paulo, Not set
GSK Investigational Site, Teresina, Not set
GSK Investigational Site, VitOria, Not set
GSK Investigational Site, Edmonton, Alberta
GSK Investigational Site, Halifax, Nova Scotia
GSK Investigational Site, Ottawa, Ontario
GSK Investigational Site, Toronto, Ontario
GSK Investigational Site, Montreal, Quebec
GSK Investigational Site, Beijing, Not set
GSK Investigational Site, Beijing, Not set
GSK Investigational Site, Beijing, Not set
GSK Investigational Site, Changchun, Not set
GSK Investigational Site, Chengdu, Not set
GSK Investigational Site, Chongqing, Not set
GSK Investigational Site, Chongqing, Not set
GSK Investigational Site, Guangzhou, Not set
GSK Investigational Site, Guangzhou, Not set
GSK Investigational Site, Hangzhou, Not set
GSK Investigational Site, Hangzhou, Not set
GSK Investigational Site, Hangzhou, Not set
GSK Investigational Site, Hangzhou, Not set
GSK Investigational Site, Harbin, Not set
GSK Investigational Site, Jinan, Not set
GSK Investigational Site, Kunming, Not set
GSK Investigational Site, Meizhou, Not set
GSK Investigational Site, Nanchang, Not set
GSK Investigational Site, Nanchang, Not set
GSK Investigational Site, Shanghai, Not set
GSK Investigational Site, Shanghai, Not set
GSK Investigational Site, Shenzhen, Not set
GSK Investigational Site, Taiyuan, Not set
GSK Investigational Site, Tianjin, Not set
GSK Investigational Site, Wuhan, Not set
GSK Investigational Site, Xiamen, Not set
GSK Investigational Site, Yangzhou, Not set
GSK Investigational Site, Zhengzhou, Not set
GSK Investigational Site, Tallinn, Not set
GSK Investigational Site, Tallinn, Not set
GSK Investigational Site, Tartu, Not set
GSK Investigational Site, Helsinki, Not set
GSK Investigational Site, Tampere, Not set
GSK Investigational Site, Turku, Not set
GSK Investigational Site, Lyon, Not set
GSK Investigational Site, Marseille Cedex 5, Not set
GSK Investigational Site, Nantes cedex 1, Not set
GSK Investigational Site, Paris, Not set
GSK Investigational Site, Pessac cedex, Not set
GSK Investigational Site, Rennes Cedex, Not set
GSK Investigational Site, Rouen Cedex, Not set
GSK Investigational Site, Saint-Priest en Jarez, Not set
GSK Investigational Site, Suresnes, Not set
GSK Investigational Site, Toulouse Cedex 9, Not set
GSK Investigational Site, Villejuif Cedex, Not set
GSK Investigational Site, Berlin, Not set
GSK Investigational Site, Duesseldorf, Not set
GSK Investigational Site, Frankfurt, Not set
GSK Investigational Site, Halle, Not set
GSK Investigational Site, Luebeck, Not set
GSK Investigational Site, Mannheim, Not set
GSK Investigational Site, MUnchen, Not set
GSK Investigational Site, Munchen, Not set
GSK Investigational Site, Athens, Not set
GSK Investigational Site, Thessaloniki, Not set
GSK Investigational Site, Thessaloniki, Not set
GSK Investigational Site, Cagliari, Not set
GSK Investigational Site, Genova, Not set
GSK Investigational Site, Milano, Not set
GSK Investigational Site, Napoli, Not set
GSK Investigational Site, Padova, Not set
GSK Investigational Site, Pisa, Not set
GSK Investigational Site, Reggio Emilia, Not set
GSK Investigational Site, Roma, Not set
GSK Investigational Site, Roma, Not set
GSK Investigational Site, Rozzano MI, Not set
GSK Investigational Site, Aichi, Not set
GSK Investigational Site, Chiba, Not set
GSK Investigational Site, Fukuoka, Not set
GSK Investigational Site, Hokkaido, Not set
GSK Investigational Site, Hyogo, Not set
GSK Investigational Site, Ibaraki, Not set
GSK Investigational Site, Kanagawa, Not set
GSK Investigational Site, Kanagawa, Not set
GSK Investigational Site, Kyoto, Not set
GSK Investigational Site, Okayama, Not set
GSK Investigational Site, Osaka, Not set
GSK Investigational Site, Osaka, Not set
GSK Investigational Site, Osaka, Not set
GSK Investigational Site, Osaka, Not set
GSK Investigational Site, Osaka, Not set
GSK Investigational Site, Shizuoka, Not set
GSK Investigational Site, Tokyo, Not set
GSK Investigational Site, Tokyo, Not set
GSK Investigational Site, Daegu, Not set
GSK Investigational Site, Gyeonggi-do, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, Seoul, Not set
GSK Investigational Site, DF, Not set
GSK Investigational Site, Guadalajara, Not set
GSK Investigational Site, Guadalajara, Not set
GSK Investigational Site, Mexico City, Not set
GSK Investigational Site, Oaxaca, Not set
GSK Investigational Site, San Pedro Garza Garcia, Not set
GSK Investigational Site, Tijuana, Not set
GSK Investigational Site, Breda, Not set
GSK Investigational Site, Maastricht, Not set
GSK Investigational Site, Nijmegen, Not set
GSK Investigational Site, Utrecht, Not set
GSK Investigational Site, Bergen, Not set
GSK Investigational Site, Kristiansand, Not set
GSK Investigational Site, Lrenskog, Not set
GSK Investigational Site, Oslo, Not set
GSK Investigational Site, Stavanger, Not set
GSK Investigational Site, Tromsoe, Not set
GSK Investigational Site, Punta Pacifica Panama City Panama, Not set
GSK Investigational Site, Almada, Not set
GSK Investigational Site, Coimbra, Not set
GSK Investigational Site, Lisboa, Not set
GSK Investigational Site, Badajoz, Not set
GSK Investigational Site, BaracaldoVizcaya, Not set
GSK Investigational Site, Barcelona, Not set
GSK Investigational Site, Barcelona, Not set
GSK Investigational Site, Barcelona, Not set
GSK Investigational Site, COrdoba, Not set
GSK Investigational Site, Elche Alicante, Not set
GSK Investigational Site, Granada, Not set
GSK Investigational Site, JaEn, Not set
GSK Investigational Site, L'Hospitalet De Llobrega, Not set
GSK Investigational Site, Las Palmas De Gran Canar, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, Madrid, Not set
GSK Investigational Site, MAlaga, Not set
GSK Investigational Site, Oviedo, Not set
GSK Investigational Site, Pamplona, Not set
GSK Investigational Site, San Sebastian, Not set
GSK Investigational Site, Santander, Not set
GSK Investigational Site, Sevilla, Not set
GSK Investigational Site, Valencia, Not set
GSK Investigational Site, Valencia, Not set
GSK Investigational Site, Valencia, Not set
GSK Investigational Site, Zaragoza, Not set
GSK Investigational Site, Eskilstuna, Not set
GSK Investigational Site, Goteborg, Not set
GSK Investigational Site, Linkoping, Not set
GSK Investigational Site, Malmo, Not set
GSK Investigational Site, Stockholm, Not set
GSK Investigational Site, Stockholm, Not set
GSK Investigational Site, Uppsala, Not set
GSK Investigational Site, Kaohsiung, Not set
GSK Investigational Site, Tainan, Not set
GSK Investigational Site, Taipei, Not set
GSK Investigational Site, Taoyuan, Not set
GSK Investigational Site, Ankara, Not set
GSK Investigational Site, Ankara, Not set
GSK Investigational Site, Ankara, Not set
GSK Investigational Site, Istanbul, Not set
GSK Investigational Site, Birmingham, Not set
GSK Investigational Site, Chelmsford, Not set
GSK Investigational Site, Cheltenham, Not set
GSK Investigational Site, Edinburgh, Not set
GSK Investigational Site, Hull, Not set
GSK Investigational Site, Leeds West Yorkshire, Not set
GSK Investigational Site, London, Not set
GSK Investigational Site, London, Not set
GSK Investigational Site, Manchester, Not set
GSK Investigational Site, Sutton, Not set
Conditions: Colonic Neoplasms, Neoplasms, Colon
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Recruiting
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD).
The purpose of this study is to characterize the long-term safety and efficacy of amlitelimab in treated participants with age ≥12 years old with moderate to severe AD.
The study duration per participant will be up to 180 weeks, including:
* A screening period of up to 2 to 4 weeks
* An open label treatment period of up to 160 weeks (approximately 3 years)
* A po... Read More
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD).
The purpose of this study is to characterize the long-term safety and efficacy of amlitelimab in treated participants with age ≥12 years old with moderate to severe AD.
The study duration per participant will be up to 180 weeks, including:
* A screening period of up to 2 to 4 weeks
* An open label treatment period of up to 160 weeks (approximately 3 years)
* A post-treatment safety follow-up period of at least 20 weeks after the last dose administration
The planned number of visits will be 26 visits. Read Less
Gender:
ALL
Ages:
12 years and above
Trial Updated:
08/07/2025
Locations: Alabama Allergy & Asthma Center - Birmingham - Brookwood Boulevard- Site Number : 8400050, Birmingham, Alabama +189 locations
Alabama Allergy & Asthma Center - Birmingham - Brookwood Boulevard- Site Number : 8400050, Birmingham, Alabama
Research Solutions of Arizona- Site Number : 8400020, Litchfield Park, Arizona
Medical Dermatology Specialists- Site Number : 8400016, Phoenix, Arizona
Dermatology Trial Associates- Site Number : 8400027, Bryant, Arkansas
University Dermatology Trials, INC.- Site Number : 8400052, Newport Beach, California
Children's Hospital Colorado - Aurora- Site Number : 8400041, Aurora, Colorado
IMMUNOe International Research Centers - Centennial- Site Number : 8400024, Centennial, Colorado
Renaissance Research and Medical Group- Site Number : 8400006, Cape Coral, Florida
Life Clinical Trials - Coral Springs- Site Number : 8400040, Coral Springs, Florida
Florida Pharmaceutical Research and Associates- Site Number : 8400018, Miami, Florida
Bio-Medical Research- Site Number : 8400037, Miami, Florida
Miami Clinical Research Tower- Site Number : 8400036, Miami, Florida
Florida Research Center, Inc.- Site Number : 8400011, Miami, Florida
Clinical Research Trials of Florida- Site Number : 8400054, Tampa, Florida
Advanced Medical Research - Atlanta- Site Number : 8400044, Atlanta, Georgia
Georgia Skin & Cancer Clinic- Site Number : 8400048, Savannah, Georgia
Sneeze Wheeze And Itch Assoc- Site Number : 8400002, Normal, Illinois
Velocity Clinical Research - Sioux City- Site Number : 8400046, Sioux City, Iowa
Kentucky Advanced Medical Research- Site Number : 8400014, Murray, Kentucky
Velocity Clinical Research - Baton Rouge- Site Number : 8400005, Baton Rouge, Louisiana
Oakland Hills Dermatology- Site Number : 8400021, Auburn Hills, Michigan
The Derm Institute of West Michigan- Site Number : 8400043, Caledonia, Michigan
Michigan Dermatology Institute - Livonia- Site Number : 8401010, Livonia, Michigan
Somerset Skin Centre- Site Number : 8400038, Troy, Michigan
Grekin Skin Institute - Warren- Site Number : 8400042, Warren, Michigan
Michigan Dermatology Institute - Waterford- Site Number : 8400010, Waterford, Michigan
Forest Hills Dermatology Group @ Union Turnpike- Site Number : 8400007, Kew Gardens, New York
Aesthetic Dermatology - Woodbury- Site Number : 8400031, Woodbury, New York
Unity Clinical Research- Site Number : 8400001, Oklahoma City, Oklahoma
Dermatology Research Center of Oklahoma, PLLC - Site Number : 8400035, Tulsa, Oklahoma
The Children's Hospital of Philadelphia- Site Number : 8400009, Philadelphia, Pennsylvania
Texas Dermatology and Laser Specialists - San Antonio - Oakwell Court- Site Number : 8400053, San Antonio, Texas
Pioneer Research Solutions - Sugar Land- Site Number : 8400026, Sugar Land, Texas
Private Practice - Dr. Marthe N. Dika- Site Number : 8400022, Burlington, Wisconsin
Investigational Site Number : 0320022, General Pico, La Pampa
Investigational Site Number : 0320006, Rosario, Santa Fe
Investigational Site Number : 0320007, Rosario, Santa Fe
Investigational Site Number : 0320008, Buenos Aires, Not set
Investigational Site Number : 0320001, Buenos Aires, Not set
Investigational Site Number : 0320003, Buenos Aires, Not set
Investigational Site Number : 0320002, Buenos Aires, Not set
Investigational Site Number : 0320004, Buenos Aires, Not set
Investigational Site Number : 0320009, Buenos Aires, Not set
Investigational Site Number : 0320005, Buenos Aires, Not set
Investigational Site Number : 0360002, Kogarah, New South Wales
Investigational Site Number : 0360001, Sydney, New South Wales
Centro de Pesquisas da Clínica IBIS- Site Number : 0760002, Salvador, Bahia
HC - UFPR - Hospital de Clínicas da Universidade Federal do Paraná- Site Number : 0760022, Curitiba, Paraná
Pontifica Universidade Catolica do Parana- Site Number : 0760023, Curitiba, Paraná
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760005, Porto Alegre, Rio Grande Do Sul
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760008, Ribeirão Preto, São Paulo
Faculdade de Medicina do ABC- Site Number : 0760001, Santo André, São Paulo
Clinica de Alergia Martti Antila- Site Number : 0760006, Sorocaba, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto- Site Number : 0760003, São José Do Rio Preto, São Paulo
IDERJ - Instituto de Dermatologia e Estética do Brasil- Site Number : 0760004, Rio de Janeiro, Not set
Investigational Site Number : 1240001, Calgary, Alberta
Investigational Site Number : 1240052, Edmonton, Alberta
Investigational Site Number : 1240051, Vancouver, British Columbia
Investigational Site Number : 1240009, Etobicoke, Ontario
Investigational Site Number : 1240008, Mississauga, Ontario
Investigational Site Number : 1240011, Oakville, Ontario
Investigational Site Number : 1240004, Peterborough, Ontario
Investigational Site Number : 1240003, Richmond Hill, Ontario
Investigational Site Number : 1240012, Toronto, Ontario
Investigational Site Number : 1240002, Montreal, Quebec
Investigational Site Number : 1240010, Québec City, Quebec
Investigational Site Number : 1240006, Québec City, Quebec
Investigational Site Number : 1240044, Saskatoon, Saskatchewan
Investigational Site Number : 1520009, Osorno, Los Lagos
Investigational Site Number : 1520004, Valdivia, Los Ríos
Investigational Site Number : 1520011, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520008, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520002, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520003, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520013, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520010, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520005, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520001, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520014, Chillán, Not set
Investigational Site Number : 1560015, Beijing, Not set
Investigational Site Number : 1560008, Changchun, Not set
Investigational Site Number : 1560016, Changsha, Not set
Investigational Site Number : 1560014, Chengdu, Not set
Investigational Site Number : 1560072, Fuzhou, Not set
Investigational Site Number : 1560074, Guangzhou, Not set
Investigational Site Number : 1560044, Hangzhou, Not set
Investigational Site Number : 1560011, Hangzhou, Not set
Investigational Site Number : 1560013, Jingzhou, Not set
Investigational Site Number : 1560001, Shanghai, Not set
Investigational Site Number : 1560018, Suzhou, Not set
Investigational Site Number : 1560010, Taiyuan, Not set
Investigational Site Number : 1560073, Taizhou, Not set
Investigational Site Number : 1560019, Xinxiang, Not set
Investigational Site Number : 1560012, Yinchuan, Not set
Investigational Site Number : 1560028, Zhenjiang, Not set
Investigational Site Number : 2032105, Nový Jičín, Not set
Investigational Site Number : 2032104, Ostrava, Not set
Investigational Site Number : 2032102, Prague, Not set
Investigational Site Number : 2030003, Prague, Not set
Investigational Site Number : 2030006, Prague, Not set
Investigational Site Number : 2030007, Prague, Not set
Investigational Site Number : 2080001, Aarhus, Not set
Investigational Site Number : 2500004, Créteil, Not set
Investigational Site Number : 2500001, Lille, Not set
Investigational Site Number : 2500005, Marseille, Not set
Investigational Site Number : 2500009, Nantes, Not set
Investigational Site Number : 2500003, Paris, Not set
Investigational Site Number : 2500006, Pierre-bénite, Not set
Investigational Site Number : 2500002, Toulouse, Not set
Investigational Site Number : 2760009, Bad Bentheim, Not set
Investigational Site Number : 2762203, Berlin, Not set
Investigational Site Number : 2762201, Münster, Not set
Investigational Site Number : 2760010, Osnabrück, Not set
Investigational Site Number : 3560006, Bangalore, Not set
Investigational Site Number : 3560007, Bikaner, Not set
Investigational Site Number : 3560003, Gurugram, Not set
Investigational Site Number : 3560011, Kochi, Not set
Investigational Site Number : 3560005, Kolkata, Not set
Investigational Site Number : 3560004, Mangaluru, Not set
Investigational Site Number : 3560002, Nashik, Not set
Investigational Site Number : 3560008, Surat, Not set
Investigational Site Number : 3800003, Milan, Milano
Investigational Site Number : 3800002, Naples, Napoli
Investigational Site Number : 3800004, Naples, Napoli
Investigational Site Number : 3800007, Rome, Roma
Investigational Site Number : 3800006, Rome, Roma
Investigational Site Number : 3800005, Brescia, Not set
Investigational Site Number : 3800008, Vicenza, Not set
Investigational Site Number : 3923114, Obihiro, Hokkaido
Investigational Site Number : 3923113, Yokohama, Kanagawa
Investigational Site Number : 3923110, Sakai, Osaka
Investigational Site Number : 3923106, Mibu, Tochigi
Investigational Site Number : 3920001, Tachikawa, Tokyo
Investigational Site Number : 4100002, Ansan-si, Gyeonggi-do
Investigational Site Number : 4100016, Bucheon-si, Gyeonggi-do
Investigational Site Number : 4100003, Yangsan-si, Gyeongsangnam-do
Investigational Site Number : 4100018, Incheon, Incheon-gwangyeoksi
Investigational Site Number : 4100006, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4840001, Chihuahua, Not set
Investigational Site Number : 4840008, Durango, Not set
Investigational Site Number : 5280002, Breda, Not set
Investigational Site Number : 5280004, Rotterdam, Not set
Investigational Site Number : 5280001, Utrecht, Not set
Investigational Site Number : 6160014, Lodz, Lódzkie
Investigational Site Number : 6162411, Warsaw, Mazowieckie
Investigational Site Number : 6160009, Warsaw, Mazowieckie
Investigational Site Number : 6160007, Warsaw, Mazowieckie
Investigational Site Number : 6160006, Gdansk, Pomorskie
Investigational Site Number : 6160001, Chorzow, Slaskie
Investigational Site Number : 6160003, Katowice, Slaskie
Investigational Site Number : 6160012, Lublin, Not set
Dr. Samuels Sanchez P.S.C.- Site Number : 8400045, Caguas, Not set
GCM Medical Group - San Juan - Calle Jose Marti- Site Number : 8400049, San Juan, Not set
Caribbean Medical Research Center- Site Number : 8400028, San Juan, Not set
Investigational Site Number : 7100004, Boksburg, Not set
Investigational Site Number : 7100011, Cape Town, Not set
Investigational Site Number : 7100010, Cape Town, Not set
Investigational Site Number : 7100002, Cape Town, Not set
Investigational Site Number : 7100009, Cape Town, Not set
Investigational Site Number : 7100012, Durban, Not set
Investigational Site Number : 7100015, Durban, Not set
Investigational Site Number : 7100006, Johannesburg, Not set
Investigational Site Number : 7100007, Johannesburg, Not set
Investigational Site Number : 7100005, Middelburg, Not set
Investigational Site Number : 7100003, Pretoria, Not set
Investigational Site Number : 7100014, Pretoria, Not set
Investigational Site Number : 7240002, Badalona, Barcelona [Barcelona]
Investigational Site Number : 7240022, Sabadell, Castilla Y León
Investigational Site Number : 7242505, Alicante, Not set
Investigational Site Number : 7242501, Córdoba, Not set
Investigational Site Number : 7240021, Madrid, Not set
Investigational Site Number : 7242503, Madrid, Not set
Investigational Site Number : 7240006, Valencia, Not set
Investigational Site Number : 7560002, Buochs, Not set
Investigational Site Number : 1580006, Hsinchu, Not set
Investigational Site Number : 1583201, Kaohsiung City, Not set
Investigational Site Number : 1580002, New Taipei City, Not set
Investigational Site Number : 1583202, Taichung, Not set
Investigational Site Number : 1580007, Taichung, Not set
Investigational Site Number : 1580001, Taipei City, Not set
Investigational Site Number : 1583203, Taoyuan City, Not set
Investigational Site Number : 7920002, Aydin, Not set
Investigational Site Number : 7920003, Izmit, Not set
Investigational Site Number : 7920005, Manisa, Not set
Investigational Site Number : 7920004, Trabzon, Not set
Investigational Site Number : 8260001, London, England
Investigational Site Number : 8262601, London, London, City Of
Investigational Site Number : 8260002, Edinburgh, Not set
Investigational Site Number : 8260004, Sheffield, Not set
Conditions: Dermatitis Atopic
Pediatric cGVHD Symptom Scale
Recruiting
Background:
Some children/adolescents who have had a stem cell transplant live with chronic graft-versus-host-disease (cGVHD). cGVHD is a side effect of the transplant that can cause multiple bothersome symptoms and negatively affect a child/adolescent squality of daily life. The questionnaires that measure thesymptoms caused by cGVHD are designed for adults. Children/adolescents may not describe their symptoms in the same way. The goal of this research is to improve the way we measure how both... Read More
Background:
Some children/adolescents who have had a stem cell transplant live with chronic graft-versus-host-disease (cGVHD). cGVHD is a side effect of the transplant that can cause multiple bothersome symptoms and negatively affect a child/adolescent squality of daily life. The questionnaires that measure thesymptoms caused by cGVHD are designed for adults. Children/adolescents may not describe their symptoms in the same way. The goal of this research is to improve the way we measure how bothersome these symptoms are for children/adolescents living with cGVHD.
Objective:
To develop a questionnaire (The Pediatric cGHVD Symptom Scale) for children/adolescents living with cGVHD to identify the symptoms they are experiencing and describe how bothersome those symptoms are to them. An additional goal is to design a parent/guardian companion questionnaire that can be used to capture the symptom experiences of very young children who may not be able to complete a questionnaire.
Eligibility:
Children/adolescents ages 5-17 who are receiving treatment for cGVHD after a stem cell transplant, and their parent/guardian..
Design:
This study consists of 2 projects.
Children/adolescents with cGVHD and their parent/guardianparticipants will be grouped by the child/adolescent s age: 5-7, 8-12, and 13-17.
In project 1, participants will complete an age-appropriate questionnaire about cGVHD symptoms. The questionnaire will ask about the child/adolescent s physical functioning and emotional well-being. The parent/guardian will out fill out a companion questionnaire online. The child/adolescent will then review their completed questionnaire during an interview with a researcher and will be asked whether the questions about their symptoms were difficult to understand. The parent/guardian and child/adolescent will then be interviewed together to further explore their responses to the questionnaires. Interviews will be done in person, by phone, and online. . Based on what is learned through these interviews, the wording of the questionnaire will be improved for better comprehension and ease of response.
In project 2, participants will complete this revised questionnairefor their age group along with some other questionnaires that ask about quality of life. Both the child/adolescent and parent/guardian will fill out the questionnaires online at three separate time points.
In both projects, children/adolescents with cGVHD and their parent/guardian participants will be grouped by the child/adolescent s age: 5-7, 8-12, and 13-17.
... Read Less
Gender:
ALL
Ages:
5 years and above
Trial Updated:
08/07/2025
Locations: Children's Hospital Colorado (CHCO), Aurora, Colorado +12 locations
Children's Hospital Colorado (CHCO), Aurora, Colorado
Children s National Medical Center (CNMC), Washington, District of Columbia
Children's Healthcare of Atlanta - Egleston Hospital, Atlanta, Georgia
Lurie Children's Hospital of Chicago, Chicago, Illinois
Johns Hopkins Hospital (JHH), Baltimore, Maryland
National Institutes of Health Clinical Center, Bethesda, Maryland
University of Minnesota, Minneapolis, Minnesota
University of Pittsburgh - Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
St. Jude Children s Research Hospital, Memphis, Tennessee
Texas Children's Hospital (TCH)-Baylor, Houston, Texas
The University of Texas MD Anderson Cancer Institute, Houston, Texas
Fred Hutchinson Cancer Center (FHCC), Seattle, Washington
Children's & Women's Health Centre of British Columbia (CWHC of BC), Vancouver BC, Not set
Conditions: Graft vs Host Disease
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Recruiting
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population. Read Less
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/07/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +221 locations
University of Alabama at Birmingham, Birmingham, Alabama
Local Institution - 0229, Phoenix, Arizona
Local Institution - 0230, Phoenix, Arizona
The University of Arizona Arthritis Center, Tucson, Arizona
Kaiser Permanente, Fontana, California
Private Practice - Dr. Chandrakant V. Mehta, Hemet, California
Local Institution - 0247, La Mesa, California
Arthritis & Osteoporosis Medical Center - La Palma, La Palma, California
UCLA Clinical & Translational Research Center (CTRC), Los Angeles, California
Local Institution - 0248, Sacramento, California
Local Institution - 0253, San Diego, California
Local Institution - 0128, Santa Barbara, California
Local Institution - 0099, Denver, Colorado
Yale New Haven Hospital-Smilow Cancer Center, New Haven, Connecticut
Rheumatology Assoc. Of South Florida, Boca Raton, Florida
Local Institution - 0249, Coral Springs, Florida
Nouvelle Clinical Research, Cutler Bay, Florida
University of Florida College of Medicine, Gainesville, Florida
University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida
Omega Research Group - Orlando, Orlando, Florida
Discovery Health Research, Plantation, Florida
West Broward Rheumatology Associates, Tamarac, Florida
Genesis Clinical Research, LLC, Tampa, Florida
Local Institution - 0165, Tampa, Florida
Piedmont West, Atlanta, Georgia
Local Institution - 0228, Lawrenceville, Georgia
Local Institution - 0234, Lawrenceville, Georgia
North Georgia Rheumatology, Lawrenceville, Georgia
IBJI Morton Grove, Morton Grove, Illinois
Greater Chicago Specialty Physicians, Schaumburg, Illinois
Local Institution - 0108, Indianapolis, Indiana
Lake Cumberland Rheumatology, New Albany, Indiana
Ochsner Clinic Foundation, New Orleans, Louisiana
Local Institution - 0006, Detroit, Michigan
Saint Paul Rheumatology, Eagan, Minnesota
Atlantic Health System Overlook Medical Center, Summit, New Jersey
Local Institution - 0159, Bronx, New York
The Feinstein Institute for Medical Research, Manhasset, New York
NYU Langone Health, New York, New York
University of Rochester Medical Center, Rochester, New York
Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina
Carolinas HealthCare System SouthPark, Charlotte, North Carolina
Local Institution - 0246, Summerville, South Carolina
Local Institution - 0003, Memphis, Tennessee
Arthritis and Rheumatology Research Institute, Allen, Texas
UT Southwestern Medical Center, Dallas, Texas
Local Institution - 0088, Fort Worth, Texas
Local Institution - 0250, Houston, Texas
Local Institution - 0219, Lubbock, Texas
Advanced Rheumatology of Houston - Woodlands, The Woodlands, Texas
Carilion Clinic, Roanoke, Virginia
Swedish Medical Center, Seattle, Washington
Local Institution - 0139, Seattle, Washington
Local Institution - 0063, Franklin, Wisconsin
Instituto De Investigaciones Clinicas Quilmes, Quilmes, Buenos Aires
Fundacion Cidea, Buenos Aires, Ciudad Autónoma De Buenos Aires
APRILLUS Asistencia e Investigacion Clinica, Caba, Ciudad Autónoma De Buenos Aires
Investigaciones Clínicas Tucumán, San Miguel de Tucuman, Tucumán
Private Practice - Dr. Javier Gerardo Tartaglione, Buenos Aires, Not set
Hospital Británico de Buenos Aires, Buenos Aires, Not set
Stat Research S.A., Ciudad Autónoma de Buenos Aires, Not set
Hospital J. M. Ramos Mejía, Ciudad Autónoma de Buenos Aires, Not set
Hospital Córdoba, Córdoba, Not set
Instituto de Reumatología, Mendoza, Not set
Serviços Especializados em Reumatologia, Salvador, Bahia
Hospital Brasilia, Lago sul, Distrito Federal
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Minas Gerais
Cmip-Centro Mineiro de Pesquisa, Juiz de Fora, Minas Gerais
Hospital Universitário Evangélico Mackenzie, Curitiba, Paraná
Local Institution - 0075, Niteroi, Rio De Janeiro
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Clinica Medica Bonfiglioli, Campinas, São Paulo
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP) - HCFMRP, Ribeirão Preto, São Paulo
Hospital do Rim e Hipertensão, Sao Paulo, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo
Hospital Universitário Pedro Ernesto, Rio de Janeiro, Not set
Hospital das Clinicas FMUSP, São Paulo, Not set
Local Institution - 0048, São Paulo, Not set
Medical Center Artmed, Plovdiv, Not set
MC Excelsior, Sofia, Not set
ACIBADEM City Clinic Diagnostic-Consultative Center, Sofia, Not set
University of Calgary, Cumming School of Medicine, Calgary, Alberta
Local Institution - 0160, Hamilton, Ontario
St. Joseph's Health Care, London, Ontario
Toronto Western Hospital, Toronto, Ontario
Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski, Rimouski, Quebec
The First Afflilated Hospital of Bengbu Medical College, Bengbu, Anhui
Beijing Peking Union Medical College Hospital, Beijing, Beijing
The First Affiliated hospital of Xiamen University, Xiamen, Fujian
Guangdong Provincial People's Hospital, Guangzhou, Guangdong
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong
ShenZhen People's Hospital, Shenzhen, Guangdong
Local Institution - 0153, Baoding, Hebei
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, Henan
The First Affiliated Hospital of Zhengzhou Universtiy, Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei
Xiangya Hospital Central South University, Changsha, Hunan
ZhuZhou Central Hospital, Zhuzhou, Hunan
Local Institution - 0059, Baotou, Inner Mongolia
The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia
The First People's Hospital of Changzhou, Changzhou, Jiangsu
Jiu Jiang No.1 People's Hospital, Jiujiang, Jiangxi
Local Institution - 0071, Nanchang, Jiangxi
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
Pingxiang People's Hospital, Pingxiang, Jiangxi
The First Hospital of China Medical University, Shenyang, Liaoning
Shengjing Hospital of China Medical University, Shenyang, Liaoning
Local Institution - 0149, Jinan, Shandong
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
Huashan Hospital, Fudan University, Shanghai, Shanghai
Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai
West China Hospital, Sichuan University, Cheng Du, Sichuan
Local Institution - 0053, Tianjin, Tianjin
People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang
The first Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
Wenzhou People's Hospital, Wenzhou, Zhejiang
Shanxi Bethune Hospital, Taiyuan, Not set
Salud SURA Industriales, Medellín, Antioquia
Centro Integral de Reumatología del Caribe, Barranquilla, Atlántico
Servimed EU, Bucaramanga, Santander
Hospital Universitario San Ignacio, Bogota, Not set
Cireem Sas, Bogotá, Not set
IPS Centro Médico Julián Coronel S.A.S, Cali, Not set
Local Institution - 0058, Cali, Not set
Preventive Care, Chia, Not set
Local Institution - 0055, Medellin, Not set
Nouvel Hôpital Civil (NHC), Strasbourg, Alsace
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes, Loire-Atlantique
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, Not set
Local Institution - 0156, Tours, Not set
Universitaetsklinikum Tuebingen, Tübingen, Baden-Württemberg
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, Muenchen, Bayern
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Sachsen
Universitätsklinikum Schleswig-Holstein, Lübeck, Schleswig-Holstein
DRK-Krankenhaus Rabenstein, Chemnitz, Not set
Universitaetsklinikum Erlangen, Erlangen, Not set
Universitaetsklinikum Koeln, Köln, Not set
Klinische Forschung im medizinischen Versorgungalltag GbR, Planegg, Not set
Tuen Mun Hospital, Tuen Mun, Not set
Local Institution - 0213, Vizianagaram, Andhra Pradesh
Amber Clinic, Ahmedabad, Gujarat
Local Institution - 0243, Surat, Gujarat
Medanta The Medicity, Gurugram, Haryana
ChanRe Rheumatology And Immunology Center And Research, Bengaluru, Karnataka
ESIC Medical College, Hyderabad, Telangana
Nizam's Institute of Medical Sciences, Hyderabad, Telangana
Local Institution - 0119, Manorhamilton, Leitrim
Local Institution - 0130, Cork, Not set
Local Institution - 0157, Dublin, Not set
Local Institution - 0172, Dublin, Not set
AOU Policlinico Umberto I, Roma, Lazio
Centro Specialistico Ortopedico Traumatologico Gaetano Pini - CTO, Milano, Lombardia
Azienda Ospedaliera Universitaria Pisana, Pisa, Toscana
Azienda Ospedale - Università Padova, Padova, Veneto
Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Not set
Ospedale San Raffaele, Milano, Not set
AOU della Campania Luigi Vanvitelli, Napoli, Not set
Local Institution - 0118, Pavia, Not set
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma, Verona, Not set
Chonnam National University Hospital, Gwangju-si, Kwangju-Kwangyǒkshi
Ajou University Hospital, Suwon, Kyǒnggi-do
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0105, Jung-gu, Taegu-Kwangyǒkshi
Local Institution - 0106, Jung-gu, Taejǒn-Kwangyǒkshi
Hanyang University Seoul Hospital, Seoul, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, Kauno Apskritis
Centro Medico del Angel, Mexicali, Baja California
Boca Clinical Trials Mexico SC, Ciudad de México, Distrito Federal
Local Institution - 0027, Mexico City, Distrito Federal
Instituto para el DeSarrollo Integral de la Salud S de RL de CV, Mexico City, Distrito Federal
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal
Clinstile, S.A. de C.V., Mexico, Distrito Federal
Hospital Aranda de La Parra, Leon, Guanajuato
Local Institution - 0024, Zapopan, Jalisco
Investigacion y Biomedicina de Chihuahua, Chihuahua, Not set
Local Institution - 0014, Mexico City, Not set
Boca Clinical Trials Mexico SC, Puebla, Not set
Local Institution - 0237, Chisinau, Chișinău
Local Institution - 0238, Chisinau, Chișinău
Republican Clinical Hospital, Chisinau, Not set
Hogar Clínica San Juan de Dios, Arequipa, Not set
Instituto Peruano del Hueso y la Articulación, Lima, Not set
Centro Medico CORPAC, Lima, Not set
Investigaciones Clínicas / Instituto de Ginecología y Reproducción, Lima, Not set
Local Institution - 0196, Wroclaw, Dolnośląskie
Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy, Bydgoszcz, Kujawsko-pomorskie
Local Institution - 0244, Lublin, Lubelskie
Mak-Med Clinic Sp. Z O.O., Nadarzyn, Mazowieckie
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji, Warsaw, Mazowieckie
Rheuma Medicus Sp. z o.o., Warszawa, Mazowieckie
Local Institution - 0194, Wolomin, Mazowieckie
Centrum Medyczne Plejady, Krakow, Małopolskie
Medyczne Centrum Hetmańska, Poznan, Wielkopolskie
Local Institution - 0030, Poznań, Wielkopolskie
Nova Reuma Społka Partnerska, Bialystok, Not set
Synexus Polska Sp. z o.o. Oddzial w Poznaniu, Poznan, Not set
Local Institution - 0211, Belchatow, Łódzkie
Centrum Medyczne Pratia Katowice, Katowice, Śląskie
Local Institution - 0073, Lisbon, Not set
Centro Reumatologico Caguas, Caguas, Not set
Local Institution - 0252, San Juan, Not set
GCM Medical Group, PSC - Hato Rey Site, San Juan, Not set
Hiperdia Piața Sudului, Bucharest, Bucureşti
Hightech Medical Services SRL-Centrul pentru Studiul Metabolismului, Bucharest, București
Spital Clinic Sf. Maria, Bucharest, București
Delta Health Care, Bucharest, București
Spitalul Clinic Colentina, Bucuresti, București
CCBR Clinical Research, Bucuresti, București
Medisof Diagnostic SR, Craiova, Dolj
RK Medcenter, Iasi, Iași
Sc Medaudio-Optica Srl, Râmnicu Vâlcea, Vâlcea
Private Practice - Dr. Carina Anna Triff, Timisoara, Not set
Local Institution - 0207, Svidnik, Prešovský Kraj
Local Institution - 0206, Martin, Žilinský Kraj
Local Institution - 0232, Pretoria, GP
Local Institution - 0233, Cape Town, Western Cape
Local Institution - 0231, Stellenbosch, Western Cape
Gazi University Health Research and Application Center Gazi Hospital, Ankara, Not set
Istanbul University Cerrahpasa Medical School Internal Diseases Institute, Istanbul, Not set
Kocaeli Üniversitesi, Kocaeli, Not set
Conditions: Systemic Lupus Erythematosus
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Recruiting
This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to standard of care therapy on preventing or slowing the rate of lung function decline in adult patients with uncontrolled moderate to severe asthma.
The estimated duration is 4±1 weeks of screening and run-in period, followed by a 3-year double blinded treatment period. There will be a post-treatment follow-up (FU) period up to 12 weeks.
This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to standard of care therapy on preventing or slowing the rate of lung function decline in adult patients with uncontrolled moderate to severe asthma.
The estimated duration is 4±1 weeks of screening and run-in period, followed by a 3-year double blinded treatment period. There will be a post-treatment follow-up (FU) period up to 12 weeks. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: Cullman Research Center- Site Number : 8400001, Cullman, Alabama +244 locations
Cullman Research Center- Site Number : 8400001, Cullman, Alabama
Shoals Primary Care - Sheffield- Site Number : 8400015, Sheffield, Alabama
Chandler Clinical Research Trials- Site Number : 8400147, Chandler, Arizona
Pulmonary Associates - Deer Valley Office- Site Number : 8400155, Phoenix, Arizona
Medical Advancement Center of Arizona (MACOA)- Site Number : 8400130, Phoenix, Arizona
Del Sol Research Management - Tucson- Site Number : 8400017, Tucson, Arizona
Kern Allergy and Medical Research- Site Number : 8400037, Bakersfield, California
Vitality Clinical Research- Site Number : 8400142, Beverly Hills, California
Ascada Research - Fullerton- Site Number : 8400076, Fullerton, California
Allergy and Asthma Specialists Medical Group- Site Number : 8400162, Huntington Beach, California
Newport Native MD- Site Number : 8400054, Newport Beach, California
Prospective Research Innovations- Site Number : 8400131, Rancho Cucamonga, California
Mercy Medical Group - Midtown- Site Number : 8400164, Sacramento, California
Integrated Research of Inland- Site Number : 8400156, Upland, California
Allianz Research Institute- Site Number : 8400018, Westminster, California
Woodland Clinic - Woodland- Site Number : 8400171, Woodland, California
Central Florida Pulmonary Group - Altamonte Springs- Site Number : 8400035, Altamonte Springs, Florida
Florida Center for Allergy & Asthma Research- Site Number : 8400032, Aventura, Florida
Beautiful Minds Clinical Research Center- Site Number : 8400141, Cutler Bay, Florida
Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8400023, DeBary, Florida
Florida Lung, Asthma and Sleep Specialists (FLASS) - Polynesian- Site Number : 8400098, Kissimmee, Florida
Floridian Clinical Research - Miami Lakes- Site Number : 8400091, Miami Lakes, Florida
Ivetmar Medical Group- Site Number : 8400063, Miami, Florida
My Preferred Research- Site Number : 8400073, Miami, Florida
Research Institute of South Florida- Site Number : 8400079, Miami, Florida
Heuer M.D. Research- Site Number : 8400024, Orlando, Florida
JSV Clinical Research- Site Number : 8400150, Tampa, Florida
Appalachian Clinical Research- Site Number : 8400129, Adairsville, Georgia
Alpha Clinical Research Group - Dunwoody- Site Number : 8400116, Dunwoody, Georgia
Aeroallergy Research Laboratory- Site Number : 8400114, Savannah, Georgia
Rush University Medical Center- Site Number : 8400146, Chicago, Illinois
NorthShore University HealthSystem - Skokie- Site Number : 8400138, Skokie, Illinois
Family Allergy & Asthma - Louisville - Goss Avenue- Site Number : 8400160, Louisville, Kentucky
Allergy and Asthma Specialist- Site Number : 8400007, Owensboro, Kentucky
Avant Research Associates - Crowley- Site Number : 8400117, Crowley, Louisiana
Tandem Clinical Research - Metairie- Site Number : 8400163, Metairie, Louisiana
Javara - Privia Medical Group - Annapolis- Site Number : 8400087, Annapolis, Maryland
Kur Research - Columbia Medical- Site Number : 8400169, Columbia, Maryland
Chesapeake Clinical Research - White Marsh- Site Number : 8400119, White Marsh, Maryland
Genesis Clinical Research - Fall River- Site Number : 8400050, Fall River, Massachusetts
University of Michigan Health System - Ann Arbor- Site Number : 8400030, Ann Arbor, Michigan
Revival Research Institute - Dearborn- Site Number : 8400097, Dearborn, Michigan
Revive Research Institute - Lathrup Village- Site Number : 8400100, Lathrup Village, Michigan
Romedica- Site Number : 8400043, Rochester, Michigan
Great Lakes Research Institute Site Number : 8400111, Southfield, Michigan
Great Lakes Research Institute - Southfield- Site Number : 8400111, Southfield, Michigan
Allergy & Immunology Associates of Ann Arbor- Site Number : 8400107, Ypsilanti, Michigan
The Asthma and Allergy Center- Site Number : 8400055, Bellevue, Nebraska
Jersey City Breathing Center: Elamir Mazhar- Site Number : 8400143, Jersey City, New Jersey
Urban Health Plan- Site Number : 8400144, Bronx, New York
Clinical Research Of Gastonia- Site Number : 8400012, Gastonia, North Carolina
Advanced Respiratory and Sleep Medicine - Huntersville- Site Number : 8400056, Huntersville, North Carolina
Lapis Clinical Research - Mooresville- Site Number : 8400112, Mooresville, North Carolina
Southeastern Research Center- Site Number : 8400153, Winston-Salem, North Carolina
Asthma & Allergy Center - Toledo- Site Number : 8400051, Toledo, Ohio
St. Luke's University Hospital- Site Number : 8400099, Bethlehem, Pennsylvania
Temple University Hospital- Site Number : 8400038, Philadelphia, Pennsylvania
Allergy & Clinical Immunology Associates Pittsburgh- Site Number : 8400042, Pittsburgh, Pennsylvania
Bogan Sleep Consultants- Site Number : 8400102, Columbia, South Carolina
ADAC Research, PA- Site Number : 8400026, Greenville, South Carolina
Main Street Physician's Care- Site Number : 8400077, Little River, South Carolina
National Allergy and Asthma - North Charleston - Northside Drive- Site Number : 8400092, North Charleston, South Carolina
Health Concepts- Site Number : 8400006, Rapid City, South Dakota
REX Clinical Trials - Beaumont- Site Number : 8400135, Beaumont, Texas
South Texas Medical Research Institute - TTS Research- Site Number : 8400009, Boerne, Texas
Discovery Clinical Trials - Dallas- Site Number : 8400123, Dallas, Texas
IntraCare- Site Number : 8400003, Dallas, Texas
C & R Research Services - Houston- Site Number : 8400067, Houston, Texas
Clear Brook Medical Associates- Site Number : 8400080, Houston, Texas
Metroplex Pulmonary and Sleep Center- Site Number : 8400014, McKinney, Texas
Andante Research- Site Number : 8400140, San Antonio, Texas
DM Clinical Research - 710 Lawrence Street- Site Number : 8400103, Tomball, Texas
Burke Internal Medicine and Research- Site Number : 8400170, Burke, Virginia
University of Virginia- Site Number : 8400082, Charlottesville, Virginia
Investigational Site Number : 0560002, Brussels, Not set
Investigational Site Number : 0560003, Liège, Not set
Associacao Proar- Site Number : 0760004, Salvador, Bahia
Santa Casa de Misericordia de Belo Horizonte- Site Number : 0760006, Belo Horizonte, Minas Gerais
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760003, Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760005, Porto Alegre, Rio Grande Do Sul
Hospital Dia do Pulmão- Site Number : 0760002, Blumenau, Santa Catarina
Clinica de Alergia Martti Antila- Site Number : 0760009, Sorocaba, São Paulo
Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760007, São Paulo, Not set
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760008, São Paulo, Not set
Investigational Site Number : 1000005, Dupnitsa, Not set
Investigational Site Number : 1000012, Plovdiv, Not set
Investigational Site Number : 1000011, Ruse, Not set
Investigational Site Number : 1000002, Sofia, Not set
Investigational Site Number : 1000008, Sofia, Not set
Investigational Site Number : 1000009, Sofia, Not set
Investigational Site Number : 1000014, Sofia, Not set
Investigational Site Number : 1000013, Vratsa, Not set
Investigational Site Number : 1240028, Calgary, Alberta
Investigational Site Number : 1240020, Kelowna, British Columbia
Investigational Site Number : 1240022, Vancouver, British Columbia
Investigational Site Number : 1240004, Vancouver, British Columbia
Investigational Site Number : 1240010, Moncton, New Brunswick
Investigational Site Number : 1240015, Ajax, Ontario
Investigational Site Number : 1240018, Niagara Falls, Ontario
Investigational Site Number : 1240011, Toronto, Ontario
Investigational Site Number : 1240001, Toronto, Ontario
Investigational Site Number : 1240007, Toronto, Ontario
Investigational Site Number : 1240003, Windsor, Ontario
Investigational Site Number : 1240014, Montreal, Quebec
Investigational Site Number : 1240017, Montreal, Quebec
Investigational Site Number : 1240023, Montreal, Quebec
Investigational Site Number : 1240002, Quebec City, Quebec
Investigational Site Number : 1240025, Sherbrooke, Quebec
Investigational Site Number : 1240024, Saskatoon, Saskatchewan
Investigational Site Number : 1560017, Beijing, Not set
Investigational Site Number : 1560022, Beijing, Not set
Investigational Site Number : 1560030, Beijing, Not set
Investigational Site Number : 1560024, Bengbu, Not set
Investigational Site Number : 1560006, Dongguan, Not set
Investigational Site Number : 1560007, Guangzhou, Not set
Investigational Site Number : 1560019, Guiyang, Not set
Investigational Site Number : 1560003, Hebei, Not set
Investigational Site Number : 1560023, Hefei, Not set
Investigational Site Number : 1560029, Luzhou, Not set
Investigational Site Number : 1560002, Nanchang, Not set
Investigational Site Number : 1560014, Nanjing, Not set
Investigational Site Number : 1560008, Ningbo, Not set
Investigational Site Number : 1560031, Ningbo, Not set
Investigational Site Number : 1560001, Shanghai, Not set
Investigational Site Number : 1560011, Taiyuan, Not set
Investigational Site Number : 1560012, Taiyuan, Not set
Investigational Site Number : 1560004, Tianjin, Not set
Investigational Site Number : 1560025, Tianjin, Not set
Investigational Site Number : 1560009, Wuxi, Not set
Investigational Site Number : 1560028, Xi'an, Not set
Investigational Site Number : 1560020, Xiamen, Not set
Investigational Site Number : 1560013, Yichang, Not set
Investigational Site Number : 1560010, Yueyang, Not set
Investigational Site Number : 1560021, Zhengzhou, Not set
Investigational Site Number : 3000003, Athens, Not set
Investigational Site Number : 3000010, Athens, Not set
Investigational Site Number : 3000007, Athens, Not set
Investigational Site Number : 3000004, Athens, Not set
Investigational Site Number : 3000006, Athens, Not set
Investigational Site Number : 3000005, Athens, Not set
Investigational Site Number : 3000002, Ioannina, Not set
Investigational Site Number : 3000009, Palaio Faliro, Not set
Investigational Site Number : 3000008, Thessaloniki, Not set
Investigational Site Number : 3000001, Thessaloniki, Not set
Investigational Site Number : 3480011, Budapest, Not set
Investigational Site Number : 3480012, Budapest, Not set
Investigational Site Number : 3480008, Debrecen, Not set
Investigational Site Number : 3480005, Edelény, Not set
Investigational Site Number : 3480004, Hajdúnánás, Not set
Investigational Site Number : 3480007, Mosonmagyaróvár, Not set
Investigational Site Number : 3480003, Püspökladány, Not set
Investigational Site Number : 3480013, Szekszárd, Not set
Investigational Site Number : 3480006, Szombathely, Not set
Investigational Site Number : 3480001, Százhalombatta, Not set
Investigational Site Number : 3560011, Ahmedabad, Not set
Investigational Site Number : 3560003, Chandigarh, Not set
Investigational Site Number : 3560008, Coimbatore, Not set
Investigational Site Number : 3560016, Faridabad, Not set
Investigational Site Number : 3560001, Jaipur, Not set
Investigational Site Number : 3560019, Jodhpur, Not set
Investigational Site Number : 3560002, Kozhikode, Not set
Investigational Site Number : 3560014, Lucknow, Not set
Investigational Site Number : 3560006, Mangaluru, Not set
Investigational Site Number : 3560018, Mysuru, Not set
Investigational Site Number : 3560009, Nagpur, Not set
Investigational Site Number : 3560012, Nagpur, Not set
Investigational Site Number : 3560015, New Delhi, Not set
Investigational Site Number : 3560020, Pune, Not set
Investigational Site Number : 3560004, Vadodara, Not set
Investigational Site Number : 3720001, Cork, Not set
Investigational Site Number : 3720003, Dublin, Not set
Investigational Site Number : 4100007, Busan, Busan-gwangyeoksi
Investigational Site Number : 4100008, Wonju, Gangwon-do
Investigational Site Number : 4100006, Daegu, Gyeongsangbuk-do
Investigational Site Number : 4100010, Bupyeong-gu, Incheon-gwangyeoksi
Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100009, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100004, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4100005, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 4840006, Mexico City, Ciudad De Mexico
Investigational Site Number : 4840002, Guadalajara, Jalisco
Investigational Site Number : 4840008, Monterrey, Nuevo León
Investigational Site Number : 4840005, Monterrey, Nuevo León
Investigational Site Number : 4840014, San Juan Del Río, Querétaro
Investigational Site Number : 4840010, Villahermosa, Tabasco
Investigational Site Number : 4840016, Chihuahua, Not set
Investigational Site Number : 4840012, Chihuahua, Not set
Investigational Site Number : 4840001, Durango, Not set
Investigational Site Number : 4840013, Oaxaca, Not set
Investigational Site Number : 4840003, Veracruz, Not set
Investigational Site Number : 5120001, Muscat, Not set
Investigational Site Number : 5120002, Muscat, Not set
Investigational Site Number : 6040001, Lima, Not set
Investigational Site Number : 6040002, Lima, Not set
Investigational Site Number : 6040003, Piura, Not set
Cardio Pulmonary Research Center- Site Number : 8400126, Guaynabo, Not set
FDI Clinical Research- Site Number : 8400121, San Juan, Not set
University of Puerto Rico - Medical Sciences Campus- Site Number : 8400128, San Juan, Not set
Investigational Site Number : 6420010, Baia Mare, Not set
Investigational Site Number : 6420005, Bragadiru, Not set
Investigational Site Number : 6420007, Brasov, Not set
Investigational Site Number : 6420002, Brașov, Not set
Investigational Site Number : 6420004, Codlea, Not set
Investigational Site Number : 6420011, Craiova, Not set
Investigational Site Number : 6420001, Deva, Not set
Investigational Site Number : 6420008, Pitești, Not set
Investigational Site Number : 6420009, Timisoara, Not set
Investigational Site Number : 6820008, Mecca, Not set
Investigational Site Number : 7030003, Levice, Not set
Investigational Site Number : 7030001, Poprad, Not set
Investigational Site Number : 7030002, Spišská Nová Ves, Not set
Investigational Site Number : 7030005, Topoľčany, Not set
Investigational Site Number : 7100006, Benoni, Not set
Investigational Site Number : 7100013, Cape Town, Not set
Investigational Site Number : 7100001, Cape Town, Not set
Investigational Site Number : 7100004, Cape Town, Not set
Investigational Site Number : 7100012, Chatsworth, Not set
Investigational Site Number : 7100003, Durban, Not set
Investigational Site Number : 7100009, Durban, Not set
Investigational Site Number : 7100014, Johannesburg, Not set
Investigational Site Number : 7100002, Pretoria, Not set
Investigational Site Number : 7100008, Somerset West, Not set
Investigational Site Number : 7100007, Vereeniging, Not set
Investigational Site Number : 1580003, Douliu, Not set
Investigational Site Number : 1580001, Kaohsiung City, Not set
Investigational Site Number : 1580004, Taichung, Not set
Investigational Site Number : 1580002, Taipei City, Not set
Investigational Site Number : 7920007, Ankara, Not set
Investigational Site Number : 7920008, Ankara, Not set
Investigational Site Number : 7920003, Balcali Adana, Not set
Investigational Site Number : 7920001, Istanbul, Not set
Investigational Site Number : 7920006, Izmir, Not set
Investigational Site Number : 7920009, Kayseri, Not set
Investigational Site Number : 7920004, Kirikkale, Not set
Investigational Site Number : 7920002, Mersin, Not set
Investigational Site Number : 7840001, Abu Dhabi, Not set
Investigational Site Number : 7840002, Abu Dhabi, Not set
Investigational Site Number : 8260004, Cambridge, Cambridgeshire
Investigational Site Number : 8260003, Oxford, Oxfordshire
Investigational Site Number : 8260002, Bradford, Not set
Investigational Site Number : 8260005, Liverpool, Not set
Investigational Site Number : 8260001, Newcastle Upon Tyne, Not set
Investigational Site Number : 8260008, Wakefield, Not set
Conditions: Asthma
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Recruiting
This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Rituximab and mosunetuzumab are monoclonal antibodies. They bind to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab may be more effective at extending survival in patients with NLPHL than the usual... Read More
This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Rituximab and mosunetuzumab are monoclonal antibodies. They bind to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab may be more effective at extending survival in patients with NLPHL than the usual approach with rituximab. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: City of Hope Comprehensive Cancer Center, Duarte, California +33 locations
City of Hope Comprehensive Cancer Center, Duarte, California
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida
UM Sylvester Comprehensive Cancer Center at Doral, Doral, Florida
UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
University of Kansas Cancer Center, Kansas City, Kansas
University of Kansas Cancer Center-Overland Park, Overland Park, Kansas
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
University of Kansas Cancer Center - North, Kansas City, Missouri
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth, Middletown, New Jersey
Memorial Sloan Kettering Bergen, Montvale, New Jersey
Memorial Sloan Kettering Commack, Commack, New York
Memorial Sloan Kettering Westchester, Harrison, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Memorial Sloan Kettering Nassau, Uniondale, New York
Wake Forest University Health Sciences, Winston-Salem, North Carolina
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
M D Anderson Cancer Center, Houston, Texas
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
University of Virginia Cancer Center, Charlottesville, Virginia
VCU Massey Comprehensive Cancer Center, Richmond, Virginia
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Conditions: Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
Fabry Disease Registry & Pregnancy Sub-registry
Recruiting
The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The primary objectives of the Registry are:
* To enhance the understanding of the variability, progression, and natural history of F... Read More
The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
The primary objectives of the Registry are:
* To enhance the understanding of the variability, progression, and natural history of Fabry disease, including heterozygous females with the disease;
* To assist the Fabry medical community with the development of recommendations for monitoring patients and reports on patient outcomes to help optimize patient care;
* To characterize and describe the Fabry population as a whole;
* To evaluate the long-term safety and effectiveness of Fabrazyme®
Fabry Pregnancy Sub-registry: This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Fabry Registry, regardless of whether she is receiving disease-specific therapy (such as enzyme replacement therapy with agalsidase beta) and irrespective of the commercial product with which she may be treated. Data from the Sub-registry are also used to fulfill various global regulatory requirements, to support product development/reimbursement, and for other research and non-research-related purposes. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician. If a patient consents to this Sub-registry, information about the patient's medical and obstetric history, pregnancy, and birth will be collected, and, if a patient consents to data collection for her infant, data on infant growth through month 36 postpartum will be collected. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
08/07/2025
Locations: University of Alabama Birmingham- Nephrology- Site Number : 840018, Birmingham, Alabama +275 locations
University of Alabama Birmingham- Nephrology- Site Number : 840018, Birmingham, Alabama
University of Alabama Birmingham- Nephrology- Site Number : 840073, Birmingham, Alabama
Phoenix Children's Hospital- Site Number : 840003, Phoenix, Arizona
University of Arizona- Site Number : 840015, Tucson, Arizona
Arkansas Childrens Hospital- Site Number : 840109, Little Rock, Arkansas
University of Arkansas for Medical Sciences- Site Number : 840113, Little Rock, Arkansas
University of California at Irvine- Site Number : 840036, Irvine, California
Southern California Permanente Medical Group- Site Number : 840108, Los Angeles, California
USC Health Sciences Center Dept of Genetics- Site Number : 840082, Los Angeles, California
UCLA School Of Medicine- Site Number : 840088, Los Angeles, California
Children's Hospital Oakland- Site Number : 840029, Oakland, California
Children's Hospital of Orange County- Site Number : 840074, Orange, California
Stanford Unviersity MC Dept of Genetics- Site Number : 840022, Palo Alto, California
UC Davis MIND Institute- Site Number : 840010, Sacramento, California
Kaiser Permanente Hospital- Site Number : 840042, Sacramento, California
University of California at San Diego- Site Number : 840007, San Diego, California
University of California at San Francisco- Site Number : 840051, San Francisco, California
Yale - Site Number : 840047, New Haven, Connecticut
Children's National Medical Center- Site Number : 840067, Washington, District of Columbia
University Hematology Oncology- Site Number : 840075, Coral Springs, Florida
University of Florida Dept of Genetics- Site Number : 840083, Gainesville, Florida
University of Florida Pediatrics Genetics- Site Number : 840121, Jacksonville, Florida
University Of Miami SOM- Site Number : 840006, Miami, Florida
University of Florida-Genetics- Site Number : 840096, Tampa, Florida
Emory University School of Medicine- Human Genetics- Site Number : 840060, Decatur, Georgia
University of Colorado at Denver Genetics- Site Number : 840068, Aurora, Illinois
Ann and Robert Lurie Children's Hospital- Site Number : 840013, Chicago, Illinois
Rush University Medical Center Genetics- Site Number : 840079, Chicago, Illinois
Indianapolis University School of Medicine- Site Number : 840027, Indianapolis, Indiana
University of Iowa- Site Number : 840032, Iowa City, Iowa
University of Kansas Medical Center- Site Number : 840071, Kansas City, Kansas
University of Louisville- Genetics- Site Number : 840030, Louisville, Kentucky
Ochsner Medical Center- Site Number : 840120, Baton Rouge, Louisiana
Tulane University Medical Center- Site Number : 840001, New Orleans, Louisiana
Maine Medical Center Pediatrics- Site Number : 840064, Portland, Maine
John Hopkins- Site Number : 840044, Baltimore, Maryland
Massachusetts General Hospital-Genetics- Site Number : 840062, Boston, Massachusetts
Brigham and Women's Hospital-Neurology- Site Number : 840103, Boston, Massachusetts
Boston Children's Hospital- Site Number : 840092, Boston, Massachusetts
Baystate Health- Site Number : 840002, Springfield, Massachusetts
University of Michigan Pediatrics- Site Number : 840107, Ann Arbor, Michigan
Children's Hospital of Michigan- Site Number : 840066, Detroit, Michigan
Spectrum for Health- Site Number : 840019, Grand Rapids, Michigan
Infusion Associates- Site Number : 840050, Grand Rapids, Michigan
Children's Health Care- Site Number : 840114, Minneapolis, Minnesota
Children's Hospital and Clinics of Minnesota- Site Number : 840046, Minneapolis, Minnesota
University of Minnesota Medical Center Pediatrics- Site Number : 840076, Minneapolis, Minnesota
University of Missouri Health System Department of Genetics- Site Number : 840031, Columibia, Missouri
Washington University of St. Louis- Site Number : 840100, Saint Louis, Missouri
Shodair Children's Hospital- Site Number : 840090, Helena, Montana
University of Nebraska Medical Center- Pediatrics- Site Number : 840084, Omaha, Nebraska
Children's Specialty Center of Nevada- Site Number : 840008, Las Vegas, Nevada
Cooper Health Center- Site Number : 840098, Camden, New Jersey
Joseph M. Sanzari Children's Hospital- Site Number : 840101, Hackensack, New Jersey
Atlantic Health System- Site Number : 840099, Morristown, New Jersey
St. Peter's University Hospital- Site Number : 840016, New Brunswick, New Jersey
St. Joseph's Children's Hospital- Site Number : 840057, Paterson, New Jersey
Northwell Health- Site Number : 840102, Manhasset, New York
New York University School Of Medicine- Site Number : 840040, New York, New York
Metropolitan Hospital Center- Site Number : 840110, New York, New York
Icahn School of Medicine at Mount Sinai- Site Number : 840080, New York, New York
University of Rochester Medical Center SOM- Site Number : 840105, Rochester, New York
State University of New York- Site Number : 840052, Syracuse, New York
New York Medical College- Site Number : 840039, Valhalla, New York
Carolinas Medical Center- Site Number : 840065, Charlotte, North Carolina
Duke University Medical Center Genetics Dept- Site Number : 840045, Durham, North Carolina
Cincinnati Children's Hospital-Genetics- Site Number : 840033, Cincinnati, Ohio
University Hospitals Cleveland Medical Center- Site Number : 840119, Cleveland, Ohio
Cleveland Clinic Foundation Pediatrics- Site Number : 840048, Cleveland, Ohio
Nationwide Children's Hospital- Site Number : 840091, Columbus, Ohio
Ohio State University Department of Genetics- Site Number : 840097, Columbus, Ohio
LSD Data Registry Site LLC- Site Number : 840094, Dublin, Ohio
Oregon Health and Science University- Site Number : 840116, Portland, Oregon
Oregon Health and Scinece University- Site Number : 840038, Portland, Oregon
Geisinger- Site Number : 840111, Danville, Pennsylvania
Penn State University Medical Center-Neurology- Site Number : 840104, Hershey, Pennsylvania
Children's Hospital of Philadelphia HUP Medical Genetics- Site Number : 840089, Philadelphia, Pennsylvania
Children's Hospital of Philadelphia- Site Number : 840034, Philadelphia, Pennsylvania
University of Pittsburgh- Site Number : 840023, Pittsburgh, Pennsylvania
Rhode Island Hospital Genetics- Site Number : 840053, Providence, Rhode Island
Greenwood Genetcs- Site Number : 840055, Greenville, South Carolina
Vanderbilt University Hospital-Pediatrics- Site Number : 840049, Nashville, Tennessee
Baylor Research Center- Site Number : 840058, Dallas, Texas
Cook Children's Health Care System- Site Number : 840024, Fort Worth, Texas
University of Utah Department of Medical Genetics- Site Number : 840043, Salt Lake City, Utah
University of Virginia School of Medicine-Pediatrics- Site Number : 840078, Charlottesville, Virginia
O&O Alpan, LLC- Site Number : 840025, Fairfax, Virginia
Children's Hospital of the Kings Daughters- Site Number : 840072, Norfolk, Virginia
Seattle Children's Hospital- Site Number : 840028, Seattle, Washington
University Of Washington Medical Center- Site Number : 840059, Seattle, Washington
Multicare Health System ¿ Mary Bridge Childrens Hospital- Site Number : 840115, Tacoma, Washington
Children's Hospital of Wisconsin-Pediatrics- Site Number : 840054, Milwaukee, Wisconsin
Investigational Site Number : 153032, Ciudad Autónoma de Buenos Aires, Buenos Aires
Investigational Site Number : 153172, Buenos Aires, Not set
Investigational Site Number : 153130, Buenos Aires, Not set
Investigational Site Number : 153194, Catamarca, Not set
Investigational Site Number : 032005, La Rioja, Not set
Investigational Site Number : 032004, Santa Fe, Not set
Investigational Site Number : 036013, Westmead, New South Wales
Investigational Site Number : 151069, Westmead, New South Wales
Investigational Site Number : 153063, Brisbane, Queensland
Investigational Site Number : 151002, Adelaide, South Australia
Investigational Site Number : 153040, Parkville, Victoria
Investigational Site Number : 153090, Perth, Western Australia
Investigational Site Number : 150722, Antwerp, Not set
Investigational Site Number : 153133, Antwerp, Not set
Investigational Site Number : 153001, Brussels, Not set
Investigational Site Number : 0560008, Brussels, Not set
Investigational Site Number : 150517, Brussels, Not set
Investigational Site Number : 151668, Leuven, Not set
Investigational Site Number : 154275, Liège, Not set
Investigational Site Number : 153100, Seraing, Not set
Clínica Senhor do Bonfim LTDA- Site Number : 076008, Feira de Santana, Bahia
Medicordis- Site Number : 076009, Brasília, Distrito Federal
Hospital Geral e Maternidade de Cuiabá- Site Number : 076006, Cuiabá, Mato Grosso
CTDR - Centro de Tratamento de Doenças Renais EIRELI- Site Number : 076007, Uberlândia, Minas Gerais
Instituto do Rim do Paraná- Site Number : 076004, Curitiba, Paraná
Instituto de Medicina Integral Professor Fernando Figueira - IMIP - Site Number : 076005, Recife, Pernambuco
Saúde Center Clínica - Clínica Médica Nossa Senhora de Fátima - Site Number : 076002, Tapejara, Rio Grande Do Sul
Hospital Universitário Professor Polydoro Ernani de São Thiago - UFSC- Site Number : 076012, Florianopolis, Santa Catarina
Hospital e Maternidade Celso Pierro - PUC-Campinas- Site Number : 076013, Campinas, São Paulo
Serviço de Terapia Renal de Ourinhos- Site Number : 076011, Ourinhos, São Paulo
Instituto de Genética e Erros Inatos do Metabolismo- Site Number : 076001, São Paulo, Not set
Investigational Site Number : 153169, Sofia, Not set
Investigational Site Number : 100001, Sofia, Not set
Investigational Site Number : 124014, Calgary, Alberta
Investigational Site Number : 124002, Edmonton, Alberta
Investigational Site Number : 124010, Vancouver, British Columbia
Investigational Site Number : 124011, Vancouver, British Columbia
Investigational Site Number : 124019, Winnipeg, Manitoba
Investigational Site Number : 124022, Moncton, New Brunswick
Investigational Site Number : 124023, St. John's, Newfoundland and Labrador
Investigational Site Number : 124008, Halifax, Nova Scotia
Investigational Site Number : 124005, Kingston, Ontario
Investigational Site Number : 124021, London, Ontario
Investigational Site Number : 124006, Toronto, Ontario
Investigational Site Number : 124009, Toronto, Ontario
Investigational Site Number : 124013, Montreal, Quebec
Investigational Site Number : 124001, Sherbrooke, Quebec
Investigational Site Number : 152004, Antofagasta, Not set
Investigational Site Number : 152001, Coquimbo, Not set
Investigational Site Number : 152003, Iquique, Not set
Investigational Site Number : 152002, Santiago, Not set
Investigational Site Number : 152005, Vallenar, Not set
Investigational Site Number : 153165, Beijing, Not set
Investigational Site Number : 1560003, Hangzhou, Not set
Investigational Site Number : 1560002, Jinan, Not set
Investigational Site Number : 1560004, Nanjing, Not set
Investigational Site Number : 1560001, Shanghai, Not set
Investigational Site Number : 153163, Shanghai, Not set
Investigational Site Number : 170001, Bogotá, Not set
Investigational Site Number : 1910001, Rijena, Not set
Investigational Site Number : 1910002, Zagreb, Not set
Investigational Site Number : 153126, Praha 2, Not set
Investigational Site Number : 153041, Copenhagen, Not set
Investigational Site Number : 151229, København Ø, Not set
Investigational Site Number : 153106, Tartu, Not set
Investigational Site Number : 153024, Turku, Not set
Investigational Site Number : 250005, Bordeaux, Not set
Investigational Site Number : 250002, BRON Cedex, Not set
Investigational Site Number : 250001, Garches, Not set
Investigational Site Number : 250007, Lille, Not set
Investigational Site Number : 250004, St-priest-en-jarez, Not set
Investigational Site Number : 250009, Strasbourg, Not set
Investigational Site Number : 153013, Berlin, Not set
Investigational Site Number : 154150, Gießen, Not set
Investigational Site Number : 153147, Münster, Not set
Investigational Site Number : 153011, Würzburg, Not set
Investigational Site Number : 344001, Kowloon, Not set
Investigational Site Number : 3480002, Budapest, Not set
Investigational Site Number : 3480003, Létavértes, Not set
Investigational Site Number : 3480005, Pécs, Not set
Investigational Site Number : 3480004, Sopron, Not set
Investigational Site Number : 356003, Ahmedabad, Not set
Investigational Site Number : 356001, Kolkata, Not set
Investigational Site Number : 3560004, Secunderabad, Not set
Investigational Site Number : 356002, Vellore, Not set
Investigational Site Number : 360001, Jakarta, Not set
Investigational Site Number : 380002, Bassano Del Grappa (VI), Not set
Investigational Site Number : 380019, Bologna, Not set
Investigational Site Number : 380004, Firenze, Not set
Investigational Site Number : 380013, Firenze, Not set
Investigational Site Number : 380005, Genova, Not set
Investigational Site Number : 380009, Milano, Not set
Investigational Site Number : 380006, Milano, Not set
Investigational Site Number : 380003, Modena, Not set
Investigational Site Number : 380010, Monza (MB), Not set
Investigational Site Number : 380008, Napoli, Not set
Investigational Site Number : 380007, Rimini, Not set
Investigational Site Number : 380012, Roma, Not set
Investigational Site Number : 380011, Torino, Not set
Investigational Site Number : 380001, Udine, Not set
Investigational Site Number : 380014, Vittoria (RG), Not set
Investigational Site Number : 392007, Kobe, Hyogo
Investigational Site Number : 153201, Nangoku-shi, Kochi
Investigational Site Number : 153205, Abeno-ku, Osaka
Investigational Site Number : 153217, Chiba, Not set
Investigational Site Number : 392006, Niigata, Not set
Investigational Site Number : 153204, Tokyo, Not set
Investigational Site Number : 153178, Yangsan-si, Gyeongsangnam-do
Investigational Site Number : 154208, Yangsan, Gyeongsangnam-do
Investigational Site Number : 153180, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 153196, Seoul, Seoul-teukbyeolsi
Investigational Site Number : 154246, Busan, Not set
Investigational Site Number : 153191, Daejeon, Not set
Investigational Site Number : 153228, Jeju-si, Not set
Investigational Site Number : 153192, Seoul, Not set
Investigational Site Number : 151149, Seoul, Not set
Investigational Site Number : 153188, Seoul, Not set
Investigational Site Number : 153212, Seoul, Not set
Investigational Site Number : 153222, Seoul, Not set
Investigational Site Number : 154273, Suwon-si, Not set
Investigational Site Number : 154244, Vilnius, Not set
Investigational Site Number : 154652, Vilnius, Not set
Investigational Site Number : 458001, Jalan Pahang, Not set
Investigational Site Number : 458002, Kuala Lumpur, Not set
Investigational Site Number : 151171, Amsterdam, Not set
Investigational Site Number : 153004, Amsterdam, Not set
Investigational Site Number : 153141, Bergen, Not set
Investigational Site Number : 604002, Callao, Not set
Investigational Site Number : 608001, Manila, Not set
Investigational Site Number : 150575, Warszawa, Not set
Investigational Site Number : 620005, Lisboa, Not set
Investigational Site Number : 620001, Porto, Not set
Investigational Site Number : 154099, Bucuresti, Not set
Investigational Site Number : 154164, Bucuresti, Not set
Investigational Site Number : 153081, Cluj-napoca, Not set
Investigational Site Number : 643001, Moscow, Not set
Investigational Site Number : 643003, Nizhny Novgorod, Not set
Investigational Site Number : 643002, Saint-Peterburg, Not set
Investigational Site Number : 682002, Al Mubarraz, Not set
Investigational Site Number : 6880001, Novi Sad, Not set
Investigational Site Number : 702001, Singapore, Not set
Investigational Site Number : 703001, Bratislava, Not set
Investigational Site Number : 705001, Slovenj Gradec, Not set
Investigational Site Number : 154146, A Coruña, A Coruña [La Coruña]
Investigational Site Number : 154159, A Coruña, A Coruña [La Coruña]
Investigational Site Number : 153237, Barcelona, Barcelona [Barcelona]
Investigational Site Number : 154147, Barcelona, Barcelona [Barcelona]
Investigational Site Number : 154204, Barcelona, Catalunya [Cataluña]
Investigational Site Number : 154135, Barakaldo, Pais Vasco
Investigational Site Number : 153213, Vigo, Pontevedra [Pontevedra]
Investigational Site Number : 154136, Tarragona, Tarragona [Tarragona]
Investigational Site Number : 153067, Barcelona, Not set
Investigational Site Number : 153077, Barcelona, Not set
Investigational Site Number : 154123, Barcelona, Not set
Investigational Site Number : 153050, Göteborg, Not set
Investigational Site Number : 151484, Stockholm, Not set
Investigational Site Number : 154093, Chiayi, Not set
Investigational Site Number : 152152, Hualien, Not set
Investigational Site Number : 153088, Kaohsiung City, Not set
Investigational Site Number : 152246, Kaohsiung City, Not set
Investigational Site Number : 152244, Kaohsiung, Not set
Investigational Site Number : 151534, New Taipei City, Not set
Investigational Site Number : 151500, Putz City, Chia-yi, Not set
Investigational Site Number : 151179, Taichung, Not set
Investigational Site Number : 151181, Taichung, Not set
Investigational Site Number : 153248, Tainan City, Not set
Investigational Site Number : 152153, Tainan City, Not set
Investigational Site Number : 151182, Taipei City, Not set
Investigational Site Number : 152226, Taipei City, Not set
Investigational Site Number : 152321, Taipei, Not set
Investigational Site Number : 153158, Taoyuan City, Not set
Investigational Site Number : 764003, Bangkok, Not set
Investigational Site Number : 764004, Bangkok, Not set
Investigational Site Number : 764001, Bangkok, Not set
Investigational Site Number : 764005, Khon Kaen, Not set
Investigational Site Number : 151340, Cambridge, Cambridgeshire
Investigational Site Number : 152287, Birmingham, England
Investigational Site Number : 151646, London, London, City Of
Investigational Site Number : 150303, London, London, City Of
Investigational Site Number : 152361, Salford, Manchester
Investigational Site Number : 154196, Belfast, Not set
Investigational Site Number : 151123, London, Not set
Investigational Site Number : 150455, Manchester, Not set
Investigational Site Number : 154212, Hanoi, Not set
Conditions: Fabry Disease
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
Recruiting
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of a novel T-Cell bispecific (TCB), glofitamab, administered by intravenous (IV) infusion as a single agent and in combination with obinutuzumab, following pre-treatment with a one-time, fixed dose of obinutuzumab. This entry-into-human (EIH) study is divided in 3 parts: dose escalation (Parts I and II) and dose expansion (Part III). Single-partic... Read More
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of a novel T-Cell bispecific (TCB), glofitamab, administered by intravenous (IV) infusion as a single agent and in combination with obinutuzumab, following pre-treatment with a one-time, fixed dose of obinutuzumab. This entry-into-human (EIH) study is divided in 3 parts: dose escalation (Parts I and II) and dose expansion (Part III). Single-participant dose-escalation cohorts will be used in Part I, followed by conversion to multiple participant dose-escalation cohorts (Part II), in order to define a tentative maximum tolerated dose (MTD) or optimal biological dose (OBD). The expansion cohorts (Part III) will be initiated when the tentative MTD/OBD is defined, to further evaluate the safety, PK and therapeutic activity of glofitamab. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: Ingalls Memorial Hospital, Harvey, Illinois +37 locations
Ingalls Memorial Hospital, Harvey, Illinois
University of Michigan, Ann Arbor, Michigan
Washington University, Saint Louis, Missouri
Mount Sinai Medical Center, New York, New York
MSKCC, New York, New York
Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania
Hunstman Cancer Institute, Salt Lake City, Utah
Swedish Cancer Inst., Seattle, Washington
Prince of Wales Hospital, Randwick, New South Wales
Peter Maccallum Cancer Centre, Melbourne, Victoria
Cliniques Universitaires St-Luc, Bruxelles, Not set
UZ Gent, Gent, Not set
Princess Margaret Cancer Center, Toronto, Ontario
Vseobecna Fakultni Nemocnice v Praze, I. Interni Klinika - Klinika Hematoonkologie VFN a 1. LF UK, Praha 2, Not set
Rigshospitalet, København Ø, Not set
Helsinki University Central Hospital, Helsinki, Not set
Hopital Henri Mondor, Creteil, Not set
Hopital Claude Huriez, Lille, Not set
CHU Saint Eloi, Montpellier, Not set
Ch Lyon Sud, Pierre Benite, Not set
CHU DE RENNES - CHU Pontchaillou, Rennes, Not set
AUSL della Romagna, Ravenna, Emilia-Romagna
Fond. IRCCS Istituto Nazionale Tumori, Milano, Lombardia
Istituto Clinico Humanitas, Rozzano, Lombardia
A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette, Torino, Piemonte
Auckland Cancer Trial Centre, Auckland, Not set
Uniwersyteckie Centrum Kliniczne, Gda?sk, Not set
Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?, Not set
Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, Warszawa, Not set
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroc?aw, Not set
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona
Hospital Duran i Reynals L'Hospitalet, L'Hospitalet de Llobregat, Barcelona
Hospital Universitario Marques de Valdecilla, Santander, Cantabria
Hospital del Mar, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Univ. 12 de Octubre, Madrid, Not set
China Medical University Hospital, Taichung, Not set
National Taiwan Universtiy Hospital, Taipei, Not set
Conditions: Non-Hodgkin's Lymphoma
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Recruiting
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO.
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression to IMV/ECMO. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: Research Site, Mobile, Alabama +450 locations
Research Site, Mobile, Alabama
Research Site, Phoenix, Arizona
Research Site, Phoenix, Arizona
Research Site, Tucson, Arizona
Research Site, Chula Vista, California
Research Site, Fresno, California
Research Site, La Mesa, California
Research Site, Los Angeles, California
Research Site, Newport Beach, California
Research Site, Torrance, California
Research Site, Colorado Springs, Colorado
Research Site, Denver, Colorado
Research Site, Washington, District of Columbia
Research Site, Bradenton, Florida
Research Site, Bradenton, Florida
Research Site, Gainesville, Florida
Research Site, Jacksonville, Florida
Research Site, Lakeland, Florida
Research Site, Miami, Florida
Research Site, Saint Petersburg, Florida
Research Site, South Pasadena, Florida
Research Site, Tampa, Florida
Research Site, Atlanta, Georgia
Research Site, Boise, Idaho
Research Site, Chicago, Illinois
Research Site, Elmhurst, Illinois
Research Site, Evanston, Illinois
Research Site, Fort Wayne, Indiana
Research Site, Iowa City, Iowa
Research Site, Kansas City, Kansas
Research Site, Louisville, Kentucky
Research Site, Baton Rouge, Louisiana
Research Site, New Orleans, Louisiana
Research Site, Shreveport, Louisiana
Research Site, Annapolis, Maryland
Research Site, Silver Spring, Maryland
Research Site, Springfield, Massachusetts
Research Site, Worcester, Massachusetts
Research Site, Detroit, Michigan
Research Site, Royal Oak, Michigan
Research Site, Saint Paul, Minnesota
Research Site, Columbia, Missouri
Research Site, Kansas City, Missouri
Research Site, Saint Louis, Missouri
Research Site, Brooklyn, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, Potsdam, New York
Research Site, Chapel Hill, North Carolina
Research Site, Greenville, North Carolina
Research Site, Winston-Salem, North Carolina
Research Site, Columbus, Ohio
Research Site, Oklahoma City, Oklahoma
Research Site, Corvallis, Oregon
Research Site, Portland, Oregon
Research Site, Philadelphia, Pennsylvania
Research Site, Providence, Rhode Island
Research Site, Greenville, South Carolina
Research Site, Sioux Falls, South Dakota
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, El Paso, Texas
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, Salt Lake City, Utah
Research Site, Charlottesville, Virginia
Research Site, Green Bay, Wisconsin
Research Site, Milwaukee, Wisconsin
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, Caba, Not set
Research Site, La Plata, Not set
Research Site, Mar del Plata, Not set
Research Site, Munro, Not set
Research Site, Rosario, Not set
Research Site, Adelaide, Not set
Research Site, Bedford Park, Not set
Research Site, New Lambton Heights, Not set
Research Site, Port Macquarie, Not set
Research Site, South Brisbane, Not set
Research Site, Kortrijk, Not set
Research Site, Ottignies, Not set
Research Site, Roeselare, Not set
Research Site, Yvoir, Not set
Research Site, Belo Horizonte, Not set
Research Site, Campinas, Not set
Research Site, Caxias do Sul, Not set
Research Site, Curitiba, Not set
Research Site, Curitiba, Not set
Research Site, Indaiatuba, Not set
Research Site, Jaú, Not set
Research Site, Natal, Not set
Research Site, Niterói, Not set
Research Site, Passo Fundo, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Recife, Not set
Research Site, Ribeirão Preto, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Salvador, Not set
Research Site, Sao Paulo, Not set
Research Site, São Caetano do Sul, Not set
Research Site, São José do Rio Preto, Not set
Research Site, São Paulo, Not set
Research Site, Montana, Not set
Research Site, Pernik, Not set
Research Site, Pleven, Not set
Research Site, Ruse, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Varna, Not set
Research Site, Calgary, Alberta
Research Site, New Westminster, British Columbia
Research Site, Winnipeg, Manitoba
Research Site, Winnipeg, Manitoba
Research Site, Winnipeg, Manitoba
Research Site, Brampton, Ontario
Research Site, Ottawa, Ontario
Research Site, Ottawa, Ontario
Research Site, Toronto, Ontario
Research Site, Levis, Quebec
Research Site, Montreal, Quebec
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Saskatoon, Saskatchewan
Research Site, Quebec, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Chengdu, Not set
Research Site, Chengdu, Not set
Research Site, Chongqing, Not set
Research Site, Fuyang, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Haikou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Jining, Not set
Research Site, Nanchang, Not set
Research Site, Nantong, Not set
Research Site, Qingdao, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenzhen, Not set
Research Site, Tianjin, Not set
Research Site, Weifang, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Yantai, Not set
Research Site, Yinchuan, Not set
Research Site, Yueyang, Not set
Research Site, Zhengzhou, Not set
Research Site, Bogota DC, Not set
Research Site, Floridablanca, Not set
Research Site, Medellin, Not set
Research Site, Soledad, Not set
Research Site, Villavicencio, Not set
Research Site, Benesov, Not set
Research Site, Brno, Not set
Research Site, Hradec Kralove, Not set
Research Site, Kolin, Not set
Research Site, Kyjov, Not set
Research Site, Mlada Boleslav, Not set
Research Site, Praha 10, Not set
Research Site, Praha 5, Not set
Research Site, Praha, Not set
Research Site, Aalborg, Not set
Research Site, Aarhus N, Not set
Research Site, Copenhagen Ø, Not set
Research Site, Herning, Not set
Research Site, Hillerød, Not set
Research Site, Hvidovre, Not set
Research Site, Kolding, Not set
Research Site, København, Not set
Research Site, Odense C, Not set
Research Site, Vejle, Not set
Research Site, Alexandria, Not set
Research Site, Cairo, Not set
Research Site, Cairo, Not set
Research Site, New Cairo, Not set
Research Site, Amiens Cedex 1, Not set
Research Site, Angers, Not set
Research Site, Brest Cedex, Not set
Research Site, Créteil, Not set
Research Site, Dijon, Not set
Research Site, La Tronche, Not set
Research Site, Le Coudray Cedex, Not set
Research Site, Montpellier Cedex 5, Not set
Research Site, Nantes Cedex 1, Not set
Research Site, Orléans Cedex 2, Not set
Research Site, Strasbourg Cedex, Not set
Research Site, Strasbourg, Not set
Research Site, Tours, Not set
Research Site, Augsburg, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Hamburg, Not set
Research Site, Hannover, Not set
Research Site, Kiel, Not set
Research Site, Köln, Not set
Research Site, Leverkusen, Not set
Research Site, Marburg, Not set
Research Site, Regensburg, Not set
Research Site, Rosenheim, Not set
Research Site, Rostock, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Exohi Thessaloniki, Not set
Research Site, Heraklion, Not set
Research Site, Ioannina, Not set
Research Site, Thessaloniki, Not set
Research Site, Hong Kong, Not set
Research Site, Shatin, Not set
Research Site, Balassagyarmat, Not set
Research Site, Budapest, Not set
Research Site, Budapest, Not set
Research Site, Debrecen, Not set
Research Site, Győr, Not set
Research Site, Kistarcsa, Not set
Research Site, Nyíregyháza, Not set
Research Site, Pécs, Not set
Research Site, Ahmedabad, Not set
Research Site, Ahmedabad, Not set
Research Site, Belagavi, Not set
Research Site, Chennai, Not set
Research Site, Gurgaon, Not set
Research Site, Gurugram, Not set
Research Site, Hyderabad, Not set
Research Site, Hyderabad, Not set
Research Site, Kanpur, Not set
Research Site, Mumbai, Not set
Research Site, New Delhi, Not set
Research Site, New Delhi, Not set
Research Site, New Delhi, Not set
Research Site, Pune, Not set
Research Site, Thane, Not set
Research Site, Vijayawada, Not set
Research Site, Afula, Not set
Research Site, Ashkelon, Not set
Research Site, Beer Sheva, Not set
Research Site, Haifa, Not set
Research Site, Holon, Not set
Research Site, Jerusalem, Not set
Research Site, Petah-Tikva, Not set
Research Site, Ramat Gan, Not set
Research Site, Rehovot, Not set
Research Site, Arezzo, Not set
Research Site, Brescia, Not set
Research Site, Napoli, Not set
Research Site, Roma, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Torino, Not set
Research Site, Chiba-shi, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Gifu-shi, Not set
Research Site, Ginowan-shi, Not set
Research Site, Hanyu-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hitachi-shi, Not set
Research Site, Isehara-shi, Not set
Research Site, Izumisano-shi, Not set
Research Site, Izumo-shi, Not set
Research Site, Kamakura-shi, Not set
Research Site, Kamogawa-shi, Not set
Research Site, Kanazawa-shi, Not set
Research Site, Kanazawa-shi, Not set
Research Site, Kasuga-shi, Not set
Research Site, Kawasaki-shi, Not set
Research Site, Koshigaya-shi, Not set
Research Site, Kumagaya-shi, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Kusatsu-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Maebashi-shi, Not set
Research Site, Meguro-ku, Not set
Research Site, Mitaka-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nerima-ku, Not set
Research Site, Okayama-shi, Not set
Research Site, Okazaki-shi, Not set
Research Site, Omuta-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Sapporo-shi, Not set
Research Site, Shinagawa-ku, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Suita-shi, Not set
Research Site, Tachikawa-shi, Not set
Research Site, Takamatsu-shi, Not set
Research Site, Urasoe-shi, Not set
Research Site, Ureshino-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Daegu, Not set
Research Site, Jeonju, Not set
Research Site, Seoul, Not set
Research Site, Kota Kinabalu, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuala Lumpur, Not set
Research Site, Kuala Terengganu, Not set
Research Site, Kuantan, Not set
Research Site, Kubang Kerian, Not set
Research Site, Melaka, Not set
Research Site, Petaling Jaya, Not set
Research Site, Pulau Pinang, Not set
Research Site, Sarawak Miri, Not set
Research Site, Selangor Darul Ehsan, Not set
Research Site, Shah Alam, Not set
Research Site, Aguascalientes, Not set
Research Site, Ciudad de México, Not set
Research Site, Guadalajara, Not set
Research Site, Guadalajara, Not set
Research Site, Mexico City, Not set
Research Site, Monterrey, Not set
Research Site, San Luis Potosi, Not set
Research Site, Tlalpan, Not set
Research Site, Tlalpan, Not set
Research Site, Xalapa, Not set
Research Site, Cusco, Not set
Research Site, el Agustino, Not set
Research Site, LIma, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Piura, Not set
Research Site, Cebu, Not set
Research Site, Iloilo City, Not set
Research Site, Manila, Not set
Research Site, Quezon City, Not set
Research Site, Quezon City, Not set
Research Site, Chrzanów, Not set
Research Site, Rzeszów, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Wroclaw, Not set
Research Site, Łańcut, Not set
Research Site, Łódź, Not set
Research Site, Łęczna, Not set
Research Site, Bayamon, Not set
Research Site, Bucharest, Not set
Research Site, Bucharest, Not set
Research Site, Cluj-Napoca, Not set
Research Site, Constanta, Not set
Research Site, Iasi, Not set
Research Site, Sibiu, Not set
Research Site, Timisoara, Not set
Research Site, Jeddah, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Riyadh, Not set
Research Site, Bratislava, Not set
Research Site, Johannesburg, Soweto, Not set
Research Site, Observatory, Not set
Research Site, Parktown, Not set
Research Site, Westdene, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Málaga, Not set
Research Site, Ourense, Not set
Research Site, Palma de Mallorca, Not set
Research Site, Pamplona, Not set
Research Site, Santander, Not set
Research Site, Valencia, Not set
Research Site, Helsingborg, Not set
Research Site, Huddinge, Not set
Research Site, Lund, Not set
Research Site, Malmö, Not set
Research Site, Solna, Not set
Research Site, Stockholm, Not set
Research Site, Stockholm, Not set
Research Site, Umeå, Not set
Research Site, Västerås, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan City, Not set
Research Site, Taoyuan, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Banphaeo, Not set
Research Site, Chiang Mai, Not set
Research Site, Khlong Luang, Not set
Research Site, Khon-Kaen, Not set
Research Site, Phutthamonthon, Not set
Research Site, Ubonratchathani, Not set
Research Site, Ankara, Not set
Research Site, Diyarbakir, Not set
Research Site, Istambul, Not set
Research Site, Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Research Site, Izmir, Not set
Research Site, İzmit, Not set
Research Site, Malatya, Not set
Research Site, Ortahisar, Not set
Research Site, Bristol, Not set
Research Site, Dundee, Not set
Research Site, Glasgow, Not set
Research Site, Glasgow, Not set
Research Site, Hampshire, Not set
Research Site, Huddersfield, Not set
Research Site, Leeds, Not set
Research Site, Leicester, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Oxford, Not set
Research Site, Prescot, Not set
Research Site, Tyne And Wear, Not set
Research Site, Wythenshawe, Not set
Research Site, Hai Phong, Not set
Research Site, Hai Phong, Not set
Research Site, Hanoi, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Hochiminh city, Not set
Research Site, Hue, Not set
Conditions: Viral Lung Infection and Acute Respiratory Failure
A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
Recruiting
The protocol of this Phase 2 clinical trial consists of a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of dupilumab in participants with moderately to severely active Ulcerative Colitis (UC) with an eosinophilic phenotype.
Screening period: 2 to up to 4 weeks
Treatment period:
52-week investigational medicinal product (IMP) intervention (dupilumab or matching placebo) from Week 0 to Week 52 Open-label arm (optional): administration of... Read More
The protocol of this Phase 2 clinical trial consists of a double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of dupilumab in participants with moderately to severely active Ulcerative Colitis (UC) with an eosinophilic phenotype.
Screening period: 2 to up to 4 weeks
Treatment period:
52-week investigational medicinal product (IMP) intervention (dupilumab or matching placebo) from Week 0 to Week 52 Open-label arm (optional): administration of open-label dupilumab therapy for study participants who qualify. Follow-up period: 12 weeks The maximum duration of study per participant is up to 68 weeks. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/07/2025
Locations: Om Research- Site Number : 8400029, Apple Valley, California +76 locations
Om Research- Site Number : 8400029, Apple Valley, California
TLC Clinical Research- Site Number : 8400020, Beverly Hills, California
Ventura County Gastroenterology Medical Group- Site Number : 8400028, Camarillo, California
Palmtree Clinical Research- Site Number : 8400048, Palm Springs, California
Clinical Trials Management Services - Thousand Oaks- Site Number : 8400034, Thousand Oaks, California
Homestead Associates in Research- Site Number : 8400004, Homestead, Florida
Wellness Clinical Research - Miami Lakes - 8181 Northwest 154th Street- Site Number : 8400009, Miami Lakes, Florida
GI PROS Research- Site Number : 8400046, Naples, Florida
Advanced Research Institute - New Port Richey- Site Number : 8400026, New Port Richey, Florida
Digestive Disease Consultants - Orange Park- Site Number : 8400042, Orange Park, Florida
Tellabio International Research Services- Site Number : 8400041, Pembroke Pines, Florida
GCP Clinical Research- Site Number : 8400014, Tampa, Florida
Gastroenterology Consultants - Roswell- Site Number : 8400022, Roswell, Georgia
Sanmora Bespoke Clinical Research Solutions- Site Number : 8400043, East Orange, New Jersey
Smart Medical Research Inc- Site Number : 8400037, Jackson Heights, New York
DiGiovanna Family Care- Site Number : 8400006, Massapequa, New York
Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400008, Charlotte, North Carolina
Care Access - Lumberton- Site Number : 8400018, Lumberton, North Carolina
UPMC Presbyterian- Site Number : 8400038, Pittsburgh, Pennsylvania
Advanced Gastroenterology Associates, PA- Site Number : 8400047, Decatur, Texas
Katy Integrative Gastroenterology- Site Number : 8400027, Katy, Texas
Medrasa Clinical Research - Medrasa Sherman- Site Number : 8400039, Sherman, Texas
Texas Digestive Disease Consultants - Southlake- Site Number : 8400013, Southlake, Texas
Digestive Health Specialists of Tyler- Site Number : 8400031, Tyler, Texas
Victoria Gastroenterology- Site Number : 8400019, Victoria, Texas
Washington Gastroenterology - Bellevue- Site Number : 8400025, Bellevue, Washington
Washington Gastroenterology - Tacoma- Site Number : 8400030, Tacoma, Washington
Investigational Site Number : 0320006, Mar Del Plata, Buenos Aires
Investigational Site Number : 0320001, San Miguel de Tucumán, Tucumán
Investigational Site Number : 0320004, San Miguel de Tucumán, Tucumán
Investigational Site Number : 0320007, Buenos Aires, Not set
Investigational Site Number : 0320008, Buenos Aires, Not set
Investigational Site Number : 0320002, Buenos Aires, Not set
Investigational Site Number : 1240007, Edmonton, Alberta
Investigational Site Number : 1240010, Scarborough, Ontario
Investigational Site Number : 1240006, Montreal, Quebec
Investigational Site Number : 1240003, Montreal, Quebec
Investigational Site Number : 1520001, Concepción, Biobío
Investigational Site Number : 1520005, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520003, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520006, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520002, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 3920006, Nagoya, Aichi
Investigational Site Number : 3920005, Kashiwa, Chiba
Investigational Site Number : 3920008, Kitakyushu, Fukuoka
Investigational Site Number : 3920002, Sapporo, Hokkaido
Investigational Site Number : 3920001, Sapporo, Hokkaido
Investigational Site Number : 3920011, Kamakura, Kanagawa
Investigational Site Number : 3920010, Shimizu, Shizuoka
Investigational Site Number : 3920004, Bunkyo, Tokyo
Investigational Site Number : 3920007, Kyoto, Not set
Investigational Site Number : 3920009, Saitama, Not set
Investigational Site Number : 4100003, Haeundae-gu, Busan-gwangyeoksi
Investigational Site Number : 4100005, Daegu, Daegu-gwangyeoksi
Investigational Site Number : 4100006, Daejeon, Daejeon-gwangyeoksi
Investigational Site Number : 4100002, Wonju-si, Gangwon-do
Investigational Site Number : 4100004, Daegu, Gyeongsangbuk-do
Investigational Site Number : 4840004, Mexico City, Ciudad De Mexico
Investigational Site Number : 4840005, Saltillo, Coahuila De Zaragoza
Investigational Site Number : 4840002, Torreón, Coahuila De Zaragoza
Investigational Site Number : 4840007, Guadalajara, Jalisco
Investigational Site Number : 4840003, Chihuahua, Not set
University of Puerto Rico - Medical Sciences Campus- Site Number : 6300002, San Juan, Not set
Investigational Site Number : 7100005, Cape Town, Not set
Investigational Site Number : 7100009, Cape Town, Not set
Investigational Site Number : 7100002, Cape Town, Not set
Investigational Site Number : 7100007, Cape Town, Not set
Investigational Site Number : 7100003, Gqeberha, Not set
Investigational Site Number : 7100008, Johannesburg, Not set
Investigational Site Number : 7100006, Johannesburg, Not set
Investigational Site Number : 7100001, Johannesburg, Not set
Investigational Site Number : 7100004, Pretoria, Not set
Investigational Site Number : 1580002, Taichung, Not set
Investigational Site Number : 7920003, Gaziantep, Not set
Investigational Site Number : 7920005, Istanbul, Not set
Investigational Site Number : 7920001, Mersin, Not set
Investigational Site Number : 7920006, Zonguldak, Not set
Conditions: Colitis Ulcerative
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Recruiting
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac surgery with CPB.
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac surgery with CPB. Read Less
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/07/2025
Locations: Research Site, Tucson, Arizona +213 locations
Research Site, Tucson, Arizona
Research Site, Orange, California
Research Site, San Francisco, California
Research Site, San Francisco, California
Research Site, Stanford, California
Research Site, Aurora, Colorado
Research Site, Washington, District of Columbia
Research Site, Gainesville, Florida
Research Site, Orlando, Florida
Research Site, Weston, Florida
Research Site, Atlanta, Georgia
Research Site, Chicago, Illinois
Research Site, Fort Wayne, Indiana
Research Site, Indianapolis, Indiana
Research Site, Louisville, Kentucky
Research Site, Boston, Massachusetts
Research Site, Springfield, Massachusetts
Research Site, Detroit, Michigan
Research Site, Kansas City, Missouri
Research Site, Saint Louis, Missouri
Research Site, Lincoln, Nebraska
Research Site, Haddon Heights, New Jersey
Research Site, Rochester, New York
Research Site, Valhalla, New York
Research Site, Durham, North Carolina
Research Site, Winston-Salem, North Carolina
Research Site, Fargo, North Dakota
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Columbus, Ohio
Research Site, Philadelphia, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Charleston, South Carolina
Research Site, Dallas, Texas
Research Site, Houston, Texas
Research Site, Plano, Texas
Research Site, San Antonio, Texas
Research Site, Salt Lake City, Utah
Research Site, Charlottesville, Virginia
Research Site, Richmond, Virginia
Research Site, Seattle, Washington
Research Site, Tacoma, Washington
Research Site, Wisconsin Rapids, Wisconsin
Research Site, Buenos Aires, Not set
Research Site, Buenos Aires, Not set
Research Site, Ciudad de Buenos Aires, Not set
Research Site, Ciudad de Buenos Aires, Not set
Research Site, Corrientes, Not set
Research Site, Córdoba, Not set
Research Site, Córdoba, Not set
Research Site, Córdoba, Not set
Research Site, Santa Fe, Not set
Research Site, Adelaide, Not set
Research Site, Brisbane, Not set
Research Site, Canberra, Not set
Research Site, Heidelberg, Not set
Research Site, Monash, Not set
Research Site, Murdoch, Not set
Research Site, Southport, Not set
Research Site, Vienna, Not set
Research Site, Belo Horizonte, Not set
Research Site, Brasília, Not set
Research Site, Campinas, Not set
Research Site, Fortaleza, Not set
Research Site, Porto Alegre, Not set
Research Site, Recife, Not set
Research Site, Ribeirão Preto, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Salvador, Not set
Research Site, São José do Rio Preto, Not set
Research Site, São Paulo, Not set
Research Site, São Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Edmonton, Alberta
Research Site, Winnipeg, Manitoba
Research Site, Saint John, New Brunswick
Research Site, Hamilton, Ontario
Research Site, Kingston, Ontario
Research Site, Toronto, Ontario
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Beijing, Not set
Research Site, Fuzhou, Not set
Research Site, Gaozhou, Not set
Research Site, Guangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Huai'an, Not set
Research Site, Ningbo, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenzhen, Not set
Research Site, Shenzhen, Not set
Research Site, Tianjin, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Xi'an, Not set
Research Site, Zhengzhou City, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, Zunyi, Not set
Research Site, Bordeaux, Not set
Research Site, Dijon Cedex, Not set
Research Site, Montpellier, Not set
Research Site, Toulouse, Not set
Research Site, Dresden, Not set
Research Site, Essen, Not set
Research Site, Frankfurt am Main, Not set
Research Site, Giessen, Not set
Research Site, Halle (Saale), Not set
Research Site, Heidelberg, Not set
Research Site, Jena, Not set
Research Site, Muenster, Not set
Research Site, München, Not set
Research Site, Stuttgart, Not set
Research Site, Trier, Not set
Research Site, Alexandroupolis, Not set
Research Site, Athens, Not set
Research Site, Athens, Not set
Research Site, Thessaloniki, Not set
Research Site, Hong Kong, Not set
Research Site, Bangalore, Not set
Research Site, Bangalore, Not set
Research Site, Delhi, Not set
Research Site, Delhi, Not set
Research Site, Gurgaon, Not set
Research Site, Hyderabad, Not set
Research Site, Mysuru, Not set
Research Site, Secunderabad, Not set
Research Site, Haifa, Not set
Research Site, Haifa, Not set
Research Site, Petah-Tikva, Not set
Research Site, Ramat Gan, Not set
Research Site, Bari, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Napoli, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Chuo-ku, Not set
Research Site, Kamakura-shi, Not set
Research Site, Kawasaki-shi, Not set
Research Site, Minato-ku, Not set
Research Site, Okayama-shi, Not set
Research Site, Sagamihara-shi, Not set
Research Site, Suginami, Not set
Research Site, Urayasu, Not set
Research Site, Anyang-si, Not set
Research Site, Bucheon-si, Not set
Research Site, Busan, Not set
Research Site, Daegu, Not set
Research Site, Daegu, Not set
Research Site, Seongnam-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Groningen, Not set
Research Site, Maastricht, Not set
Research Site, Rotterdam, Not set
Research Site, Białystok, Not set
Research Site, Bielsko-Biała, Not set
Research Site, Chrzanów, Not set
Research Site, Grudziądz, Not set
Research Site, Katowice, Not set
Research Site, Kraków, Not set
Research Site, Poznań, Not set
Research Site, Szczecin, Not set
Research Site, Tychy, Not set
Research Site, Warszawa, Not set
Research Site, Łódź, Not set
Research Site, Łódź, Not set
Research Site, Coimbra, Not set
Research Site, Lisboa, Not set
Research Site, Lisboa, Not set
Research Site, A Coruña, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Córdoba, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Navarra, Not set
Research Site, Santander, Not set
Research Site, Sevilla, Not set
Research Site, Valencia, Not set
Research Site, Valladolid, Not set
Research Site, Hualien City, Not set
Research Site, Kaohsiung, Not set
Research Site, New Taipei, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taipei City, Not set
Research Site, Taipei, Not set
Research Site, Ankara, Not set
Research Site, Antalya, Not set
Research Site, Istanbul, Not set
Research Site, Istanbul, Not set
Research Site, İstanbul, Not set
Research Site, İstanbul, Not set
Research Site, İstanbul, Not set
Research Site, Menemen/Izmir, Not set
Research Site, Odunpazarı, Not set
Research Site, Cambridge, Not set
Research Site, Clydebank, Not set
Research Site, Edinburgh, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, London, Not set
Research Site, Newcastle upon Tyne, Not set
Conditions: Chronic Kidney Disease, CKD, Cardiac Disease, Cardiopulmonary Bypass
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Recruiting
The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Volrustomig or Rilvegostomig in combination with CTX; or Datopotamab deruxtecan (Dato-DXd) in combination with Durvalumab or Rilvegostomig and single agent platinum chemotherapy in participants with resectable, early-stage non-small cell lung cancer.
The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Volrustomig or Rilvegostomig in combination with CTX; or Datopotamab deruxtecan (Dato-DXd) in combination with Durvalumab or Rilvegostomig and single agent platinum chemotherapy in participants with resectable, early-stage non-small cell lung cancer. Read Less
Gender:
ALL
Ages:
Between 18 years and 95 years
Trial Updated:
08/07/2025
Locations: Research Site, Little Rock, Arkansas +97 locations
Research Site, Little Rock, Arkansas
Research Site, Los Angeles, California
Research Site, Oakland, California
Research Site, New Haven, Connecticut
Research Site, Stuart, Florida
Research Site, Gainesville, Georgia
Research Site, Chicago, Illinois
Research Site, Baltimore, Maryland
Research Site, Baltimore, Maryland
Research Site, Boston, Massachusetts
Research Site, Saint Louis Park, Minnesota
Research Site, Omaha, Nebraska
Research Site, Buffalo, New York
Research Site, Cleveland, Ohio
Research Site, Pittsburgh, Pennsylvania
Research Site, Chattanooga, Tennessee
Research Site, Memphis, Tennessee
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, Fairfax, Virginia
Research Site, Seattle, Washington
Research Site, Charleroi, Not set
Research Site, Gent, Not set
Research Site, Gent, Not set
Research Site, Leuven, Not set
Research Site, Roeselare, Not set
Research Site, Edmonton, Alberta
Research Site, Winnipeg, Manitoba
Research Site, Montréal, Quebec
Research Site, Montréal, Quebec
Research Site, Avignon Cedex, Not set
Research Site, Bobigny, Not set
Research Site, Bordeaux, Not set
Research Site, Limoges, Not set
Research Site, Rennes Cedex, Not set
Research Site, Rouen, Not set
Research Site, Suresnes, Not set
Research Site, Toulon, Not set
Research Site, Kecskemét, Not set
Research Site, Székesfehérvár, Not set
Research Site, Tatabánya, Not set
Research Site, Törökbálint, Not set
Research Site, Dublin 7, Not set
Research Site, Dublin 8, Not set
Research Site, Dublin, Not set
Research Site, Galway, Not set
Research Site, Aviano, Not set
Research Site, Brescia, Not set
Research Site, Catanzaro, Not set
Research Site, Firenze, Not set
Research Site, Genova, Not set
Research Site, Meldola, Not set
Research Site, Milano, Not set
Research Site, Monza, Not set
Research Site, Padova, Not set
Research Site, Perugia, Not set
Research Site, Pisa, Not set
Research Site, Roma, Not set
Research Site, Rozzano, Not set
Research Site, Busan, Not set
Research Site, Chungcheongbuk-do, Not set
Research Site, Seongnam-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon, Not set
Research Site, Suwon, Not set
Research Site, Lisboa, Not set
Research Site, Lisboa, Not set
Research Site, Lisboa, Not set
Research Site, Lisbon, Not set
Research Site, Porto, Not set
Research Site, Porto, Not set
Research Site, Porto, Not set
Research Site, A Coruña, Not set
Research Site, Alicante, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Córdoba, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Málaga, Not set
Research Site, Reus, Not set
Research Site, Sevilla, Not set
Research Site, Terrassa, Not set
Research Site, Valencia, Not set
Research Site, Liuying, Not set
Research Site, New Taipei, Not set
Research Site, Tainan City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Ankara, Not set
Research Site, Istanbul, Not set
Research Site, Izmir, Not set
Conditions: Non-small Cell Lung Cancer
1 - 12 of 3905